200,000+ products from a single source!
sales@angenechem.com
Home > Pyridines > 105462-24-6
105462-24-6 | Phosphonic acid, [1-hydroxy-2-(3-pyridinyl)ethylidene]bis-
CAS No: 105462-24-6 Catalog No: AG00HANG MDL No:MFCD01706268
Product Description
Catalog Number:
AG00HANG
Chemical Name:
Phosphonic acid, [1-hydroxy-2-(3-pyridinyl)ethylidene]bis-
CAS Number:
105462-24-6
Molecular Formula:
C7H11NO7P2
Molecular Weight:
283.1123
MDL Number:
MFCD01706268
IUPAC Name:
(1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphonic acid
InChI:
InChI=1S/C7H11NO7P2/c9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6/h1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15)
InChI Key:
IIDJRNMFWXDHID-UHFFFAOYSA-N
SMILES:
OP(=O)(C(P(=O)(O)O)(Cc1cccnc1)O)O
UNII:
KM2Z91756Z
Properties
Complexity:
339
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
283.001g/mol
Formal Charge:
0
Heavy Atom Count:
17
Hydrogen Bond Acceptor Count:
8
Hydrogen Bond Donor Count:
5
Isotope Atom Count:
0
Molecular Weight:
283.113g/mol
Monoisotopic Mass:
283.001g/mol
Rotatable Bond Count:
4
Topological Polar Surface Area:
148A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-3.1
Literature
| Title | Journal |
|---|---|
| Modulation of paraoxonase 1 (PON1) activity and protein N-homocysteinylation by bisphosphonates in rats. | Chemico-biological interactions 20161125 |
| Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro). | European journal of cancer (Oxford, England : 1990) 20121101 |
| Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study. | Spine 20121101 |
| Sensitized photodecomposition of organic bisphosphonates by singlet oxygen. | Journal of the American Chemical Society 20121017 |
| Bisphosphonates improve trabecular bone mass and normalize cortical thickness in ovariectomized, osteoblast connexin43 deficient mice. | Bone 20121001 |
| Third-generation bisphosphonates for treatment of sensorineural hearing loss in otosclerosis. | Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 20121001 |
| Effect of bisphosphonates on bone mineral density and fracture prevention in gastric cancer patients after gastrectomy. | Journal of clinical gastroenterology 20120901 |
| Age effect on bone mineral density changes in breast cancer patients receiving anastrozole: results from the ARBI prospective clinical trial. | Journal of cancer research and clinical oncology 20120901 |
| Efficacy of intravenously administered ibandronate in postmenopausal Korean women with insufficient response to orally administered bisphosphonates. | Journal of bone and mineral metabolism 20120901 |
| Time to onset of efficacy in fracture reduction with current anti-osteoporosis treatments. | Journal of bone and mineral metabolism 20120901 |
| Evidence for safety and efficacy of risedronate in men with osteoporosis over 4 years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study. | Bone 20120901 |
| Risedronate-associated scleritis: a case report and review of the literature. | Clinical rheumatology 20120901 |
| Subsequent hip fracture in osteoporotic hip fracture patients. | Yonsei medical journal 20120901 |
| Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120801 |
| The association between automatic generic substitution and treatment persistence with oral bisphosphonates. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120801 |
| The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120801 |
| Risedronate improves bone mineral density in Crohn's disease: a two year randomized controlled clinical trial. | Journal of Crohn's & colitis 20120801 |
| Lipid profiles within the SABRE trial of anastrozole with and without risedronate. | Breast cancer research and treatment 20120801 |
| Effect of risedronate on bone in renal transplant recipients. | Journal of the American Society of Nephrology : JASN 20120801 |
| Children and adolescents treated with neridronate for osteogenesis imperfecta show no evidence of any osteonecrosis of the jaw. | Journal of bone and mineral metabolism 20120701 |
| Preventive effect of risedronate on bone loss and frailty fractures in elderly women treated with anastrozole for early breast cancer. | Journal of bone and mineral metabolism 20120701 |
| A study of changes in bone metabolism in cases of gender identity disorder. | Journal of bone and mineral metabolism 20120701 |
| Risedronate improves bone mineral density in Crohn's disease: a complementary mechanism. | Journal of Crohn's & colitis 20120701 |
| 25 hydroxyvitamin D serum levels influence adequate response to bisphosphonate treatment in postmenopausal osteoporosis. | Bone 20120701 |
| Management of osteoporosis among the elderly with other chronic medical conditions. | Drugs & aging 20120701 |
| Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures? | The Journal of bone and joint surgery. British volume 20120701 |
| Efficacy and safety of monthly oral minodronate in patients with involutional osteoporosis. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120601 |
| A role for C-terminal cross-linking telopeptide (CTX) level to predict the development of bisphosphonate-related osteonecrosis of the jaws (BRONJ) following oral surgery? | Irish journal of medical science 20120601 |
| Combined pubic rami and sacral osteoporotic fractures: a prospective study. | Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology 20120601 |
| Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis. | The Journal of clinical endocrinology and metabolism 20120601 |
| Inflammatory rheumatic disorders and bone. | Current rheumatology reports 20120601 |
| Successful treatment of calcific uraemic arteriolopathy with bisphosphonates. | Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20120514 |
| Prospective comparison of the therapeutic effect of teriparatide with that of combined vertebroplasty with antiresorptive agents for the treatment of new-onset adjacent vertebral compression fracture after percutaneous vertebroplasty. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120501 |
| Long-term outcomes of children and adolescents who had cerebral palsy with secondary osteoporosis. | Current medical research and opinion 20120501 |
| Effects of alendronate and risedronate on bone material properties in actively forming trabecular bone surfaces. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20120501 |
| Effectiveness of Teriparatide in women over 75 years of age with severe osteoporosis: 36-month results from the European Forsteo Observational Study (EFOS). | Calcified tissue international 20120501 |
| Persistence and compliance of medications used in the treatment of osteoporosis--analysis using a large scale, representative, longitudinal German database. | International journal of clinical pharmacology and therapeutics 20120501 |
| Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report. | Journal of managed care pharmacy : JMCP 20120501 |
| Prospective evaluation of free radicals and antioxidant activity following 6-month risedronate treatment in patients with postmenopausal osteoporosis. | Rheumatology international 20120401 |
| Osteoporosis medication prescribing in British Columbia and Ontario: impact of public drug coverage. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120401 |
| Bisphosphonates as antimyeloma drugs. | Leukemia 20120401 |
| Influence of bone affinity on the skeletal distribution of fluorescently labeled bisphosphonates in vivo. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20120401 |
| Medication adherence and fracture risk among patients on bisphosphonate therapy in a large United States health plan. | Bone 20120401 |
| [Simultaneous determination of alendronate, pamidronate, ibandronate and risedronate using ion chromatography with integrated pulsed amperometric detection]. | Se pu = Chinese journal of chromatography 20120401 |
| Lipophilic analogs of zoledronate and risedronate inhibit Plasmodium geranylgeranyl diphosphate synthase (GGPPS) and exhibit potent antimalarial activity. | Proceedings of the National Academy of Sciences of the United States of America 20120313 |
| Osteoporosis, osteopenia and fracture risk: widening the therapeutic horizons. | South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20120308 |
| Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women--the six-month effect of risedronate and teriparatide. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120301 |
| Adherence to osteoporosis medications amongst Singaporean patients. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120301 |
| Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120301 |
| Exposure to bisphosphonates and risk of colorectal cancer: a population-based nested case-control study. | Cancer 20120301 |
| Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120301 |
| Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120301 |
| Effect of dosing interval duration of intermittent ibandronate treatment on the healing process of femoral osteotomy in a rat fracture model. | Calcified tissue international 20120301 |
| An evaluation of the use of oral bisphosphonates and risk of esophageal cancer. | The Annals of pharmacotherapy 20120301 |
| Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF). | Current medical research and opinion 20120301 |
| Efficacy of antiresorptive agents for preventing fractures in Japanese patients with an increased fracture risk: review of the literature. | Drugs & aging 20120301 |
| Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosis. | Annals of laboratory medicine 20120301 |
| Paget disease of bone - an update. | Australian family physician 20120301 |
| [Bisphosphonates treatment in patients with osteoporosis]. | Therapeutische Umschau. Revue therapeutique 20120301 |
| Spontaneous non-traumatic stress fractures in bilateral femoral shafts in a patient treated with bisphosphonates. | The Korean journal of internal medicine 20120301 |
| 1-(Fluoroalkylidene)-1,1-bisphosphonic acids are potent and selective inhibitors of the enzymatic activity of Toxoplasma gondii farnesyl pyrophosphate synthase. | Organic & biomolecular chemistry 20120221 |
| Immediate loading in mandible full-arch: pilot study in patients with osteoporosis in bisphosphonate therapy. | The Journal of oral implantology 20120201 |
| Adherence to treatment of primary osteoporosis and its association to fractures--the Swedish Adherence Register Analysis (SARA). | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120201 |
| Beneficial effect of risedronate for preventing recurrent hip fracture in the elderly Japanese women. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120201 |
| Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20120201 |
| Three-year experience with risedronate therapy for patients with an increased fracture risk: assessment of proximal femoral bone density and geometry by DXA. | Clinical drug investigation 20120201 |
| Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120201 |
| Efficacy of glucosamine alendronate alone & in combination with dihydroquercetin for treatment of osteoporosis in animal model. | The Indian journal of medical research 20120201 |
| Development and validation of a sensitive solid-phase-extraction (SPE) method using high-performance liquid chromatography/tandem mass spectrometry (LC-MS/MS) for determination of risedronate concentrations in human plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120115 |
| Vertebral fracture efficacy during risedronate therapy in patients using proton pump inhibitors. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101 |
| Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101 |
| Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101 |
| A reappraisal of generic bisphosphonates in osteoporosis. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101 |
| Topically administered Risedronate shows powerful anti-osteoporosis effect in ovariectomized mouse model. | Bone 20120101 |
| Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study. | European journal of endocrinology 20120101 |
| Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate. | Bone 20120101 |
| Treatment of osteoporosis in women intolerant of oral bisphosphonates. | Maturitas 20120101 |
| Factors associated with treatment of women with osteoporosis or osteopenia from a national survey. | BMC women's health 20120101 |
| Exposure to bisphosphonates and risk of cancer: a protocol for nested case-control studies using the QResearch primary care database. | BMJ open 20120101 |
| An MMP13-selective inhibitor delays primary tumor growth and the onset of tumor-associated osteolytic lesions in experimental models of breast cancer. | PloS one 20120101 |
| Evidence to inform decision makers in Thailand: a cost-effectiveness analysis of screening and treatment strategies for postmenopausal osteoporosis. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20120101 |
| Risedronate's Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis. | Clinical medicine insights. Arthritis and musculoskeletal disorders 20120101 |
| Hypertrophy of the feet and ankles presenting in primary hypertrophic osteoarthropathy or pachydermoperiostosis: a case report. | Journal of medical case reports 20120101 |
| Combination of Micronutrients for Bone (COMB) Study: bone density after micronutrient intervention. | Journal of environmental and public health 20120101 |
| Bilateral atypical insufficiency fractures of the proximal tibia and a unilateral distal femoral fracture associated with long-term intravenous bisphosphonate therapy: a case report. | Journal of medical case reports 20120101 |
| Quality and safety of medication use in primary care: consensus validation of a new set of explicit medication assessment criteria and prioritisation of topics for improvement. | BMC clinical pharmacology 20120101 |
| Vitamin K supplementation does not prevent bone loss in ovariectomized Norway rats. | Nutrition & metabolism 20120101 |
| Site specific effects of zoledronic acid during tibial and mandibular fracture repair. | PloS one 20120101 |
| Epidemiological aspects of rheumatoid arthritis patients affected by oral bisphosphonate-related osteonecrosis of the jaws. | Head & face medicine 20120101 |
| Aspirin for the older person: report of a meeting at the Royal Society of Medicine, London, 3rd November 2011. | Ecancermedicalscience 20120101 |
| Heel ultrasound can assess maintenance of bone mass in women with breast cancer. | Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20120101 |
| Impact of generic alendronate cost on the cost-effectiveness of osteoporosis screening and treatment. | PloS one 20120101 |
| Paget's disease of the mandible. | Journal of oral and maxillofacial pathology : JOMFP 20120101 |
| A qualitative evaluation of general practitioners' perceptions regarding access to medicines in New Zealand. | BMJ open 20120101 |
| Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs. | PloS one 20120101 |
| Heterogeneous glycation of cancellous bone and its association with bone quality and fragility. | PloS one 20120101 |
| Active Referral Intervention following Fragility Fractures Leads to Enhanced Osteoporosis Follow-Up Care. | Journal of osteoporosis 20120101 |
| Severe hypercalcemia due to teriparatide. | Indian journal of pharmacology 20120101 |
| Clinical utility of risedronate in postmenopausal osteoporosis: patient considerations with delayed-release formulation. | International journal of women's health 20120101 |
| Osteoporosis in men. | Journal of osteoporosis 20120101 |
| Teriparatide - Indications beyond osteoporosis. | Indian journal of endocrinology and metabolism 20120101 |
| Pathophysiology and medical treatment of pain in fibrous dysplasia of bone. | Orphanet journal of rare diseases 20120101 |
| Osteoclast activated FoxP3+ CD8+ T-cells suppress bone resorption in vitro. | PloS one 20120101 |
| [Polymers as excipients used in the technology of coated tablets containing ibandronic acid derivatives (bisphosphonates)]. | Polimery w medycynie 20120101 |
| Elcatonin in combination with risedronate is more effective than risedronate alone for relieving back pain in postmenopausal women with osteoporosis. | Biological & pharmaceutical bulletin 20120101 |
| Denosumab, a RANK ligand inhibitor, for postmenopausal women with osteoporosis. | The Annals of pharmacotherapy 20120101 |
| Spontaneous Incomplete transverse subtrochanteric femoral fracture with cortical thickening possibly secondary to risedronate use: a case report. | Journal of medical case reports 20120101 |
| Atypical bilateral pedicle fracture in long-term bisphosphonate therapy. | Spine 20111215 |
| Bisphosphonate treatment delays stress fracture remodeling in the rat ulna. | Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20111201 |
| The effect of risedronate treatment on serum osteoprotegerin and bone marker levels in postmenopausal women with osteoporosis. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20111201 |
| The invisible disease: making sense of an osteoporosis diagnosis in older age. | Qualitative health research 20111201 |
| Once-weekly risedronate for prevention of hip fracture in women with Parkinson's disease: a randomised controlled trial. | Journal of neurology, neurosurgery, and psychiatry 20111201 |
| Multicentre trial of weekly risedronate on bone density in adults with cystic fibrosis. | Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 20111201 |
| Effects of one year daily teriparatide treatment on trabecular bone material properties in postmenopausal osteoporotic women previously treated with alendronate or risedronate. | Bone 20111201 |
| Distinguishing the proapoptotic and antiresorptive functions of risedronate in murine osteoclasts: role of the Akt pathway and the ERK/Bim axis. | Arthritis and rheumatism 20111201 |
| Identifying common trajectories of joint space narrowing over two years in knee osteoarthritis. | Arthritis care & research 20111201 |
| Impact of medication adherence on health care utilization and productivity: self-reported data from a cohort of postmenopausal women on osteoporosis therapy. | Clinical therapeutics 20111201 |
| Preventive effects of zoledronic acid on bone metastasis in mice injected with human breast cancer cells. | Journal of Korean medical science 20111201 |
| Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). | PLoS computational biology 20111201 |
| Gastric ulcerogenic and healing impairment effects of risedronate, a nitrogen-containing bisphosphonate in rats. Comparison with alendronate and minodronate. | Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20111201 |
| Unusual subtrochanteric femoral insufficiency fractures associated with the prolonged use of alendronate and risedronate: a report of two cases. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20111201 |
| Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20111101 |
| Effect of stopping risedronate after long-term treatment on bone turnover. | The Journal of clinical endocrinology and metabolism 20111101 |
| Efficacy of different therapeutic regimens on hepatic osteodystrophy in chronic viral liver disease. | European journal of gastroenterology & hepatology 20111101 |
| Ion pairs of risedronate for transdermal delivery and enhanced permeation rate on hairless mouse skin. | International journal of pharmaceutics 20111031 |
| The effect of weekly risedronate on periprosthetic bone resorption following total hip arthroplasty: a randomized, double-blind, placebo-controlled trial. | The Journal of bone and joint surgery. American volume 20111019 |
| Risedronate decreases bone loss around hip implants, but how useful is its effect? | The Journal of bone and joint surgery. American volume 20111019 |
| Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS). | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20111001 |
| Bisphosphonates do not alter the rate of secondary mineralization. | Bone 20111001 |
| Cost effectiveness of denosumab compared with oral bisphosphonates in the treatment of post-menopausal osteoporotic women in Belgium. | PharmacoEconomics 20111001 |
| Physiology of the aging bone and mechanisms of action of bisphosphonates. | Biogerontology 20111001 |
| Prolonged bisphosphonate release after treatment in women with osteoporosis. Relationship with bone turnover. | Bone 20111001 |
| Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women. | Journal of clinical pharmacy and therapeutics 20111001 |
| Analysis of the comparative effectiveness of 3 oral bisphosphonates in a large managed care organization: adherence, fracture rates, and all-cause cost. | Journal of managed care pharmacy : JMCP 20111001 |
| Longitudinal change in hip fracture incidence after starting risedronate or raloxifene: an observational study. | Journal of bone and mineral metabolism 20110901 |
| Risedronate prevents persistent bone loss in prostate cancer patients treated with androgen deprivation therapy: results of a 2-year follow-up study. | Prostate cancer and prostatic diseases 20110901 |
| Comparison of the effects of elcatonin and risedronate on back and knee pain by electroalgometry using fall of skin impedance and quality of life assessment using SF-36. | Journal of bone and mineral metabolism 20110901 |
| A single infusion of zoledronic acid produces sustained remissions in Paget disease: data to 6.5 years. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110901 |
| Osteopenia: a diagnostic and therapeutic challenge. | Current osteoporosis reports 20110901 |
| Gastrointestinal tolerability and patterns of switching in patients treated for primary osteoporosis: the Swedish Adherence Register Analysis (SARA). | Calcified tissue international 20110901 |
| In vitro disintegration studies of weekly generic and branded risedronate sodium formulations available in Canada. | Current medical research and opinion 20110901 |
| Elevated international normalized ratio associated with use of dronedarone and warfarin. | The Annals of pharmacotherapy 20110901 |
| What is the optimal duration of bisphosphonate therapy? | Cleveland Clinic journal of medicine 20110901 |
| Bisphosphonate related osteonecrosis of the jaws: report of two cases. | Imaging science in dentistry 20110901 |
| Efficacy and safety of monthly 150 mg oral ibandronate in women with postmenopausal osteoporosis: a systematic review and meta-analysis of randomized controlled trials. | The Korean journal of internal medicine 20110901 |
| Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. | Lancet (London, England) 20110813 |
| Sost down-regulation by mechanical strain in human osteoblastic cells involves PGE2 signaling via EP4. | FEBS letters 20110804 |
| Effect of risedronate on osteoblast differentiation, expression of receptor activator of NF-κB ligand and apoptosis in mesenchymal stem cells. | Basic & clinical pharmacology & toxicology 20110801 |
| High-resolution computed tomography for clinical imaging of bone microarchitecture. | Clinical orthopaedics and related research 20110801 |
| Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. | Calcified tissue international 20110801 |
| Osteoporosis in men: insights for the clinician. | Therapeutic advances in musculoskeletal disease 20110801 |
| Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate. | Bone 20110701 |
| Hip structure analysis of bisphosphonate-treated Japanese postmenopausal women with osteoporosis. | Journal of bone and mineral metabolism 20110701 |
| Bone turnover markers and bone mineral density response with risedronate therapy: relationship with fracture risk and patient adherence. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110701 |
| Effect of early risedronate treatment on bone mineral density and bone turnover markers after liver transplantation: a prospective single-center study. | Transplant international : official journal of the European Society for Organ Transplantation 20110701 |
| The relationship between the chemistry and biological activity of the bisphosphonates. | Bone 20110701 |
| Risedronate does not reduce mechanical loading-related increases in cortical and trabecular bone mass in mice. | Bone 20110701 |
| Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. | The Journal of clinical endocrinology and metabolism 20110701 |
| [Diagnostic imaging of treatment in osteoporosis: SERM]. | Clinical calcium 20110701 |
| [Utility of hip structure analysis]. | Nihon rinsho. Japanese journal of clinical medicine 20110701 |
| Simultaneous bilateral subtrochanteric fractures following risedronate therapy. | Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20110701 |
| Shotgun proteomics analysis reveals new unsuspected molecular effectors of nitrogen-containing bisphosphonates in osteocytes. | Journal of proteomics 20110610 |
| Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110601 |
| Advances in glucocorticoid-induced osteoporosis. | Current rheumatology reports 20110601 |
| Effects of risedronate in Runx2 overexpressing mice, an animal model for evaluation of treatment effects on bone quality and fractures. | Calcified tissue international 20110601 |
| Efficacy of oral bisphosphonates for preventing hip fracture in disabled patients with neurological diseases: a meta-analysis of randomized controlled trials among the Japanese population. | Current medical research and opinion 20110601 |
| Efficacy of risedronate with cholecalciferol on 25-hydroxyvitamin D level and bone turnover in Korean patients with osteoporosis. | Clinical endocrinology 20110601 |
| Glucocorticoid-induced osteoporosis in men. | Journal of endocrinological investigation 20110601 |
| Evaluation of weekly risedronate treatment in postmenopausal women with osteoprotegerin. | Panminerva medica 20110601 |
| Effects of D-003 (10 mg/day) on bone mineral density of the lumbar spine and femoral neck in postmenopausal women: a randomized, double-blinded study. | The Korean journal of internal medicine 20110601 |
| Bone: Risedronate increases BMD in anorexia nervosa. | Nature reviews. Endocrinology 20110531 |
| Crystallization products of risedronate with carbohydrates and their substituted derivatives. | Molecules (Basel, Switzerland) 20110504 |
| Osteoporosis quality indicators using healthcare utilization data. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110501 |
| Effects of risedronate on bone marrow adipocytes in postmenopausal women. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110501 |
| Adherence and profile of non-persistence in patients treated for osteoporosis--a large-scale, long-term retrospective study in The Netherlands. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110501 |
| In vitro and in vivo antiplasmodial activities of risedronate and its interference with protein prenylation in Plasmodium falciparum. | Antimicrobial agents and chemotherapy 20110501 |
| Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110501 |
| Correlation between time-dependent inhibition of human farnesyl pyrophosphate synthase and blockade of mevalonate pathway by nitrogen-containing bisphosphonates in cultured cells. | Biochemical and biophysical research communications 20110422 |
| Dose-dependent differential effects of risedronate on gene expression in osteoblasts. | Biochemical pharmacology 20110415 |
| Association of menopausal vasomotor symptoms with increased bone turnover during the menopausal transition. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110401 |
| Determinants of the mechanical behavior of human lumbar vertebrae after simulated mild fracture. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110401 |
| Parathyroid hormone treatment increases fixation of orthopedic implants with gap healing: a biomechanical and histomorphometric canine study of porous coated titanium alloy implants in cancellous bone. | Calcified tissue international 20110401 |
| Bisphosphonates for post-menopausal osteoporosis: are they all the same? | QJM : monthly journal of the Association of Physicians 20110401 |
| Osteoporosis medication and reduced mortality risk in elderly women and men. | The Journal of clinical endocrinology and metabolism 20110401 |
| Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury. | Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20110401 |
| Decrease in outpatient department visits and operative interventions due to bisphosphonates in children with osteogenesis imperfecta. | Journal of children's orthopaedics 20110401 |
| The relationship between bisphosphonate use and demographic characteristics of male osteoporosis patients. | Clinics (Sao Paulo, Brazil) 20110401 |
| Relationship between blood pressure levels and bone mineral density in postmenopausal Turkish women. | Archives of medical science : AMS 20110401 |
| In brief: delayed-release risedronate (Atelvia). | The Medical letter on drugs and therapeutics 20110321 |
| Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110301 |
| Differential maintenance of cortical and cancellous bone strength following discontinuation of bone-active agents. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110301 |
| Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110301 |
| Characterization of a new solvate of risedronate. | Journal of pharmaceutical sciences 20110301 |
| Bisphosphonates in phenytoin-induced bone disorder. | Bone 20110301 |
| Osteoporosis in men: what has changed? | Current osteoporosis reports 20110301 |
| Proposed new approach for treating Paget's disease of bone. | Irish journal of medical science 20110301 |
| Effects of risedronate on cortical and trabecular bone of the mandible in glucocorticoid-treated growing rats. | American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics 20110301 |
| Prevalence, pathophysiology, screening and management of osteoporosis in gastric cancer patients. | Journal of gastric cancer 20110301 |
| Molecular characterization of a novel geranylgeranyl pyrophosphate synthase from Plasmodium parasites. | The Journal of biological chemistry 20110204 |
| [Bisphosphonate treatment of osteoporosis and other skeletal diseases]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20110204 |
| Osteonecrosis of the jaw and the role of macrophages. | Journal of the National Cancer Institute 20110202 |
| Clinical risk factor assessment had better discriminative ability than bone mineral density in identifying subjects with vertebral fracture. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110201 |
| [Osteoporosis treatment with biphosphonates: Approaches to care reality]. | Atencion primaria 20110201 |
| [Incidence of hip fractures due to osteoporosis in relation to the prescription of drugs for their prevention and treatment in Galicia, Spain]. | Atencion primaria 20110201 |
| Effects of the combination treatment of raloxifene and alendronate on the biomechanical properties of vertebral bone. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110201 |
| A reliable predictive factorial model for entrapment optimization of a sodium bisphosphonate into biodegradable microspheres. | Journal of pharmaceutical sciences 20110201 |
| The efficacy of bisphosphonates in the prevention of vertebral, hip, and nonvertebral-nonhip fractures in osteoporosis: a network meta-analysis. | Seminars in arthritis and rheumatism 20110201 |
| Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase. | Bone 20110201 |
| Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110201 |
| Diaphyseal femoral fatigue fracture associated with bisphosphonate therapy - 3 more cases. | Acta orthopaedica 20110201 |
| Treatments for osteoporosis in people with a disability. | PM & R : the journal of injury, function, and rehabilitation 20110201 |
| An evaluation of an enhanced fracture liaison service as the optimal model for secondary prevention of osteoporosis. | JRSM short reports 20110201 |
| Aqueous Extract of Black Maca (Lepidium meyenii) on Memory Impairment Induced by Ovariectomy in Mice. | Evidence-based complementary and alternative medicine : eCAM 20110101 |
| How Much of CAM Is Based on Research Evidence? | Evidence-based complementary and alternative medicine : eCAM 20110101 |
| Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW). | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110101 |
| Zoledronic acid-induced transient hepatotoxicity in a patient effectively treated for Paget's disease of bone. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110101 |
| Oral bisphosphonate compliance and persistence: a matter of choice? | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110101 |
| Risedronate improves proximal femur bone density and geometry in patients with osteoporosis or osteopenia and clinical risk factors of fractures: a practice-based observational study. | Journal of bone and mineral metabolism 20110101 |
| The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer. | Breast cancer research and treatment 20110101 |
| Computational insights into binding of bisphosphates to farnesyl pyrophosphate synthase. | Current medicinal chemistry 20110101 |
| Antifracture efficacy of currently available therapies for postmenopausal osteoporosis. | Drugs 20110101 |
| The association of adherence to osteoporosis therapies with fracture, all-cause medical costs, and all-cause hospitalizations: a retrospective claims analysis of female health plan enrollees with osteoporosis. | Journal of managed care pharmacy : JMCP 20110101 |
| Loading and skeletal development and maintenance. | Journal of osteoporosis 20110101 |
| When do bisphosphonates make the most sense? | The Journal of family practice 20110101 |
| The cost effectiveness of zoledronic acid 5 mg for the management of postmenopausal osteoporosis in women with prior fractures: evidence from Finland, Norway and the Netherlands. | Journal of medical economics 20110101 |
| A case of Marinesco-Sjögren syndrome: MRI observations of skeletal muscles, bone metabolism, and treatment with testosterone and risedronate. | Internal medicine (Tokyo, Japan) 20110101 |
| The role of the BMP signaling antagonist noggin in the development of prostate cancer osteolytic bone metastasis. | PloS one 20110101 |
| Idiopathic Parkinson's disease, osteoporosis, and hip fractures: a case report. | Case reports in neurology 20110101 |
| Preventing osteoporotic fractures in older people. | The Practitioner 20110101 |
| [Bilateral pathological sub-trochanteric fracture in a long-term biphosphonate user]. | Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca 20110101 |
| Updated recommendations for the diagnosis and management of osteoporosis: a local perspective. | Annals of Saudi medicine 20110101 |
| The facial skeleton in patients with osteoporosis: a field for disease signs and treatment complications. | Journal of osteoporosis 20110101 |
| Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management. | Breast cancer research : BCR 20110101 |
| Community-based health efforts for the prevention of falls in the elderly. | Clinical interventions in aging 20110101 |
| Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled study. | BMC musculoskeletal disorders 20110101 |
| Atrial fibrillation and the use of oral bisphosphonates. | Therapeutics and clinical risk management 20110101 |
| Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities. | Arthritis research & therapy 20110101 |
| Fracture prevention in postmenopausal women. | BMJ clinical evidence 20110101 |
| Pleiotropic effects of the HMG-CoA reductase inhibitors. | International journal of general medicine 20110101 |
| Multiple vertebral compression fractures associated with post partum osteoporosis. | Journal of back and musculoskeletal rehabilitation 20110101 |
| Role of zoledronic acid in the prevention and treatment of osteoporosis. | Clinical interventions in aging 20110101 |
| The assessment of regional skeletal metabolism: studies of osteoporosis treatments using quantitative radionuclide imaging. | Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20110101 |
| Bone health in patients with multiple sclerosis. | Journal of osteoporosis 20110101 |
| Bisphosphonates and atypical fractures of femur. | Journal of osteoporosis 20110101 |
| Emerging strategies and therapies for treatment of Paget's disease of bone. | Drug design, development and therapy 20110101 |
| PREDICT: a method for inferring novel drug indications with application to personalized medicine. | Molecular systems biology 20110101 |
| Association of Serum Phosphate and Related Factors in ESRD-Related Vascular Calcification. | International journal of nephrology 20110101 |
| Osteoimmunopathology in HIV/AIDS: A Translational Evidence-Based Perspective. | Pathology research international 20110101 |
| Comparing comorbidity measures for predicting mortality and hospitalization in three population-based cohorts. | BMC health services research 20110101 |
| If you don't take it - it can't work: the consequences of not being treated or nonadherence to osteoporosis therapy. | Therapeutics and clinical risk management 20110101 |
| Tiludronate treatment improves structural changes and symptoms of osteoarthritis in the canine anterior cruciate ligament model. | Arthritis research & therapy 20110101 |
| Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France. | BMC health services research 20110101 |
| Synchrotron radiation micro-CT at the micrometer scale for the analysis of the three-dimensional morphology of microcracks in human trabecular bone. | PloS one 20110101 |
| Clinical utility of denosumab for treatment of bone loss in men and women. | Clinical interventions in aging 20110101 |
| Efficacy and safety of bazedoxifene for postmenopausal osteoporosis. | Clinical interventions in aging 20110101 |
| Antiosteoporotic Activity of Dioscorea alata L. cv. Phyto through Driving Mesenchymal Stem Cells Differentiation for Bone Formation. | Evidence-based complementary and alternative medicine : eCAM 20110101 |
| Mikkeli Osteoporosis Index Identifies Fracture Risk Factors and Osteoporosis and Intervention Thresholds Parallel with FRAX. | Journal of osteoporosis 20110101 |
| Bone turnover is adequately suppressed in osteoporotic patients treated with bisphosphonates in daily practice. | BMC musculoskeletal disorders 20110101 |
| The evidence for efficacy of osteoporosis treatment in men with primary osteoporosis: a systematic review and meta-analysis of antiresorptive and anabolic treatment in men. | Journal of osteoporosis 20110101 |
| [Prevention and treatment of glucocorticoid-induced osteoporosis in International and Italian scenarios]. | Reumatismo 20110101 |
| The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial. | The Kurume medical journal 20110101 |
| Innegligible musculoskeletal disorders caused by zoledronic acid in adjuvant breast cancer treatment: a meta-analysis. | Journal of experimental & clinical cancer research : CR 20110101 |
| Improvement of pain and regional osteoporotic changes in the foot and ankle by low-dose bisphosphonate therapy for complex regional pain syndrome type I: a case series. | Journal of medical case reports 20110101 |
| Seven years' experience with etidronate in a woman with anorexia nervosa and vertebral fractures. | Therapeutics and clinical risk management 20110101 |
| Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2. | Journal of translational medicine 20110101 |
| Increased fracture rate in women with breast cancer: a review of the hidden risk. | BMC cancer 20110101 |
| A rare case of zolendronate infusion complication leading to glaucoma filtration surgery. | Clinical ophthalmology (Auckland, N.Z.) 20110101 |
| Stress fractures: diagnosis, treatment, and prevention. | American family physician 20110101 |
| Human ovarian tumor cells escape γδ T cell recognition partly by down regulating surface expression of MICA and limiting cell cycle related molecules. | PloS one 20110101 |
| Fracture Incidence, Quality of Life, and Back Pain during 18-Months Treatment with Teriparatide in Greek Postmenopausal Women with Osteoporosis: Results from the European Forsteo Observational Study. | Journal of osteoporosis 20110101 |
| The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women. | BMC musculoskeletal disorders 20110101 |
| Closing the osteoporosis care gap in hip fracture patients: an opportunity to decrease recurrent fractures and hospital admissions. | Journal of osteoporosis 20110101 |
| Effects of ovariectomy and ascorbic acid supplement on oxidative stress parameters and bone mineral density in rats. | The Libyan journal of medicine 20110101 |
| Aberrant axial mineralization precedes spinal ankylosis: a molecular imaging study in ank/ank mice. | Arthritis research & therapy 20110101 |
| Osteoimmunology and osteoporosis. | Arthritis research & therapy 20110101 |
| Bisphosphonates for osteoarthritis. | Arthritis research & therapy 20110101 |
| Tumour macrophages as potential targets of bisphosphonates. | Journal of translational medicine 20110101 |
| Factors Associated with Persistence with Teriparatide Therapy: Results from the DANCE Observational Study. | Journal of osteoporosis 20110101 |
| Parathyroid hormone versus bisphosphonate treatment on bone mineral density in osteoporosis therapy: a meta-analysis of randomized controlled trials. | PloS one 20110101 |
| Current guidelines have limited applicability to patients with comorbid conditions: a systematic analysis of evidence-based guidelines. | PloS one 20110101 |
| Going on a drug holiday? | Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20110101 |
| Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates. | Drug design, development and therapy 20110101 |
| Therapy of osteoporosis in men with teriparatide. | Journal of osteoporosis 20110101 |
| Closure of an open wound associated with bisphosphonate-related osteonecrosis of the jaw in a breast cancer patient. | The open dentistry journal 20110101 |
| Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study. | BMJ (Clinical research ed.) 20110101 |
| A HNMR-based metabonomics study of postmenopausal osteoporosis and intervention effects of Er-Xian Decoction in ovariectomized rats. | International journal of molecular sciences 20110101 |
| Biochemical bone turnover markers and osteoporosis in older men: where are we? | Journal of osteoporosis 20110101 |
| Osteopenia and osteoporosis in people living with HIV: multiprofessional approach. | HIV/AIDS (Auckland, N.Z.) 20110101 |
| Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis. | Drug, healthcare and patient safety 20110101 |
| Osteoporosis and bisphosphonate-related osteonecrosis of the jaw bone. | ISRN rheumatology 20110101 |
| Recommendations for Diagnosis and Management of Osteoporosis in COPD Men. | ISRN rheumatology 20110101 |
| Use of oral bisphosphonates by older adults with fractures and impaired renal function. | The Canadian journal of hospital pharmacy 20110101 |
| Glucocorticoid-induced osteoporosis - a disorder of mesenchymal stromal cells? | Frontiers in endocrinology 20110101 |
| Beneficial effect of risedronate on arterial thickening and stiffening with a reciprocal relationship to its effect on bone mass in female osteoporosis patients: a longitudinal study. | Life sciences 20101218 |
| Compliance and persistence with osteoporosis medications: a critical review of the literature. | Reviews in endocrine & metabolic disorders 20101201 |
| Risedronate metal complexes potentially active against Chagas disease. | Journal of inorganic biochemistry 20101201 |
| Management of osteoporosis in patients hospitalized for hip fractures. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20101201 |
| Response of postpoliomyelitis patients to bisphosphonate treatment. | PM & R : the journal of injury, function, and rehabilitation 20101201 |
| Outcome of patients with early breast cancer receiving nitrogen-containing bisphosphonates: a comparative analysis from the Metropolitan Detroit Cancer Surveillance System. | Clinical breast cancer 20101201 |
| [Austrian guidance for the pharmacologic treatment of osteoporosis in postmenopausal women: Addendum 2010]. | Wiener medizinische Wochenschrift (1946) 20101201 |
| Amorphigenin inhibits Osteoclast differentiation by suppressing c-Fos and nuclear factor of activated T cells. | Anatomy & cell biology 20101201 |
| Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone-releasing hormone-agonist therapy for prostate cancer. | BJU international 20101101 |
| Trabecular bone volume and osteoprotegerin expression in uremic rats given high calcium. | Pediatric nephrology (Berlin, Germany) 20101101 |
| Effects of 1 year of daily teriparatide treatment on iliacal bone mineralization density distribution (BMDD) in postmenopausal osteoporotic women previously treated with alendronate or risedronate. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20101101 |
| Osteoporosis therapies: evidence from health-care databases and observational population studies. | Calcified tissue international 20101101 |
| Effect of risedronate on osteocyte viability and bone turnover in paired iliac bone biopsies from early postmenopausal women. | Calcified tissue international 20101101 |
| Sustained vertebral antifracture efficacy of oral anti-osteoporotic therapies in postmenopausal osteoporosis. | Current medical research and opinion 20101101 |
| Bone: Risedronate and marrow adiposity. | Nature reviews. Endocrinology 20101101 |
| Optimizing clinical benefits of bisphosphonates in cancer patients with bone metastases. | The oncologist 20101101 |
| How to prevent glucocorticoid-induced osteoporosis. | Cleveland Clinic journal of medicine 20101101 |
| Glucocorticoid-induced osteoporosis in rheumatic diseases. | Clinics (Sao Paulo, Brazil) 20101101 |
| Synthesis and biological evaluation of a series of aromatic bisphosphonates. | Bioorganic & medicinal chemistry 20101015 |
| The effects of risedronate and exercise on osteoporotic lumbar rat vertebrae and their sensory innervation. | Spine 20101015 |
| Particulate adducts based on sodium risedronate and titanium dioxide for the bioavailability enhancement of oral administered bisphosphonates. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20101009 |
| Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20101001 |
| Novel bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase. | Bioorganic & medicinal chemistry letters 20101001 |
| Risk of upper gastrointestinal tract events in risedronate users switched to alendronate. | Calcified tissue international 20101001 |
| Diagnosis of Paget's disease of the pelvis using F-18 FDG PET/CT. | International journal of rheumatic diseases 20101001 |
| Use of bisphosphonates and raloxifene and risk of deep venous thromboembolism and pulmonary embolism. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100901 |
| High level of serum undercarboxylated osteocalcin in patients with incident fractures during bisphosphonate treatment. | Journal of bone and mineral metabolism 20100901 |
| In vivo microfocal computed tomography and micro-magnetic resonance imaging evaluation of antiresorptive and antiinflammatory drugs as preventive treatments of osteoarthritis in the rat. | Arthritis and rheumatism 20100901 |
| Timing of subsequent fractures after an initial fracture. | Current osteoporosis reports 20100901 |
| [Dementia and fracture]. | Clinical calcium 20100901 |
| [Jaw osteonecrosis induced by oral biphosphonates: 12 cases]. | Revue de stomatologie et de chirurgie maxillo-faciale 20100901 |
| Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100801 |
| The effect of weight training on bone mineral density and bone turnover in postmenopausal breast cancer survivors with bone loss: a 24-month randomized controlled trial. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100801 |
| Sclerostin: current knowledge and future perspectives. | Calcified tissue international 20100801 |
| Histology of an undisplaced femoral fatigue fracture in association with bisphosphonate treatment. Frozen bone with remodelling at the crack. | Acta orthopaedica 20100801 |
| Cost-effectiveness of strontium ranelate for the prevention and treatment of osteoporosis. | Expert review of pharmacoeconomics & outcomes research 20100801 |
| Effect of risedronate on bone resorption during consolidation phase of distraction osteogenesis: a rabbit model. | Journal of orthopaedic surgery (Hong Kong) 20100801 |
| Diffuse skeletal pain after administration of alendronate. | Indian journal of pharmacology 20100801 |
| Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100701 |
| Effects of the bisphosphonate risedronate on osteopenia in OASIS-deficient mice. | Journal of bone and mineral metabolism 20100701 |
| Efficacy, tolerability, and safety of risedronate in Japanese patients with Paget's disease of bone. | Journal of bone and mineral metabolism 20100701 |
| Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US National Osteoporosis Foundation guidelines. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100701 |
| How do bisphosphonates inhibit bone metastasis in vivo? | Neoplasia (New York, N.Y.) 20100701 |
| [Osteoporosis management in general practice. Preventing spontaneous bone fractures]. | MMW Fortschritte der Medizin 20100701 |
| Vitamin D and bone health: potential mechanisms. | Nutrients 20100701 |
| Open-label trial: effect of weekly risedronate immediately after transplantation in kidney recipients. | Transplantation 20100627 |
| Longitudinal change in clinical fracture incidence after initiation of bisphosphonates. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100601 |
| Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100601 |
| Effects of treatment with risedronate and alfacalcidol on progression of atherosclerosis in postmenopausal women with type 2 diabetes mellitus accompanied with osteoporosis. | The American journal of the medical sciences 20100601 |
| Risedronate-induced arthritis. | Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20100601 |
| Management of osteoporosis in a pre-menopausal woman. | Best practice & research. Clinical rheumatology 20100601 |
| Synthesis, chiral high performance liquid chromatographic resolution and enantiospecific activity of a potent new geranylgeranyl transferase inhibitor, 2-hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2-phosphonopropionic acid. | Journal of medicinal chemistry 20100513 |
| Atypical femoral fractures and bisphosphonate use. | The New England journal of medicine 20100513 |
| An in vitro assay to measure targeted drug delivery to bone mineral. | ChemMedChem 20100503 |
| Higher doses of bisphosphonates further improve bone mass, architecture, and strength but not the tissue material properties in aged rats. | Bone 20100501 |
| Inhibition of necrotic actions of nitrogen-containing bisphosphonates (NBPs) and their elimination from bone by etidronate (a non-NBP): a proposal for possible utilization of etidronate as a substitution drug for NBPs. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100501 |
| How patients' lack of knowledge about oral bisphosphonates can interfere with medical and dental care. | Journal of the American Dental Association (1939) 20100501 |
| Changes in trabecular microarchitecture in postmenopausal women on bisphosphonate therapy. | Bone 20100401 |
| Osteonecrosis of the jawbones in 2 osteoporosis patients treated with nitrogen-containing bisphosphonates: osteonecrosis reduction replacing NBP with non-NBP (etidronate) and rationale. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100401 |
| Risedronate versus alendronate in older patients with osteoporosis at high risk of fracture: an Italian cost-effectiveness analysis. | Aging clinical and experimental research 20100401 |
| Long-term use of bisphosphonates in osteoporosis. | The Journal of clinical endocrinology and metabolism 20100401 |
| Water-soluble polymer-drug conjugates for combination chemotherapy against visceral leishmaniasis. | Bioorganic & medicinal chemistry 20100401 |
| Assessment of the relationship between age and the effect of risedronate treatment in women with postmenopausal osteoporosis: a pooled analysis of four studies. | Journal of the American Geriatrics Society 20100401 |
| Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20100301 |
| Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100301 |
| The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100301 |
| The effect of risedronate on hip structural geometry in chemotherapy-induced postmenopausal women with or without use of aromatase inhibitors: a 2-year trial. | Bone 20100301 |
| Prescription of anti-osteoporosis drugs during 2004-2007-a nationwide register study in Norway. | European journal of clinical pharmacology 20100301 |
| Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity. | Bone 20100301 |
| Effect of osteoporosis treatment on mortality: a meta-analysis. | The Journal of clinical endocrinology and metabolism 20100301 |
| Response to oral bisphosphonates in subgroups of younger and older postmenopausal women. | Journal of women's health (2002) 20100301 |
| The effect of zoledronate during bone healing. | Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology 20100301 |
| [Effects of SERMs on bone health. Discrimination of SERMs from bisphosphonates in the treatment of postmenopausal osteoporosis]. | Clinical calcium 20100301 |
| Effects of risedronate on osteoarthritis of the knee. | Yonsei medical journal 20100301 |
| Genetic polymorphism of geranylgeranyl diphosphate synthase (GGSP1) predicts bone density response to bisphosphonate therapy in Korean women. | Yonsei medical journal 20100301 |
| Secondary prevention of osteoporosis in Australia: analysis of government-dispensed prescription data. | Drugs & aging 20100301 |
| Review of the cardiovascular safety of zoledronic acid and other bisphosphonates for the treatment of osteoporosis. | Clinical therapeutics 20100301 |
| Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100301 |
| Intravenous zoledronic acid: what are the indications for male osteoporosis? | Current osteoporosis reports 20100301 |
| Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100220 |
| Unusual mid-shaft fractures during long-term bisphosphonate therapy. | Clinical endocrinology 20100201 |
| Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100201 |
| Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100201 |
| Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75 years. | Bone 20100201 |
| Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100201 |
| In vivo evaluation of the presence of bone marrow in cortical porosity in postmenopausal osteopenic women. | Annals of biomedical engineering 20100201 |
| Risedronate decreases bone resorption and improves low back pain in postmenopausal osteoporosis patients without vertebral fractures. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20100201 |
| Zoledronic Acid for the treatment and prevention of primary and secondary osteoporosis. | Therapeutic advances in musculoskeletal disease 20100201 |
| [Osteoporosis]. | Revue medicale suisse 20100113 |
| Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100101 |
| A randomized, controlled dose-ranging study of risedronate in children with moderate and severe osteogenesis imperfecta. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100101 |
| Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100101 |
| Risedronate reduces intracortical porosity in women with osteoporosis. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100101 |
| Impact of bisphosphonate wash-out prior to teriparatide therapy in clinical practice. | Journal of bone and mineral metabolism 20100101 |
| Risedronate prevents early radiation-induced osteoporosis in mice at multiple skeletal locations. | Bone 20100101 |
| Confounder summary scores when comparing the effects of multiple drug exposures. | Pharmacoepidemiology and drug safety 20100101 |
| Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: results from quantitative computed tomography-based finite element analysis of the vertebral body. | Bone 20100101 |
| Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading. | Bone 20100101 |
| The impact of fewer hip fractures with risedronate versus alendronate in the first year of treatment: modeled German cost-effectiveness analysis. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20100101 |
| Differences between bisphosphonates in binding affinities for hydroxyapatite. | Journal of biomedical materials research. Part B, Applied biomaterials 20100101 |
| Risedronate on 2 consecutive days a month reduced vertebral fracture risk at 1year compared with historical placebo. | Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20100101 |
| Morphological assessment of basic multicellular unit resorption parameters in dogs shows additional mechanisms of bisphosphonate effects on bone. | Calcified tissue international 20100101 |
| Update in male osteoporosis. | The Journal of clinical endocrinology and metabolism 20100101 |
| [Diagnosis and treatment of osteoporosis in persons aged more than 75 years]. | Revista espanola de geriatria y gerontologia 20100101 |
| Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene. | Clinical interventions in aging 20100101 |
| Bisphosphonates and risk of atrial fibrillation: a meta-analysis. | Arthritis research & therapy 20100101 |
| Response of serum carboxylated and undercarboxylated osteocalcin to risedronate monotherapy and combined therapy with vitamin K(2) in corticosteroid-treated patients: a pilot study. | Internal medicine (Tokyo, Japan) 20100101 |
| Analysis of risedronate and related substances by ion-pair reversed-phase high-performance liquid chromatography with evaporative light-scattering detection. | Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20100101 |
| EVITA: a tool for the early evaluation of pharmaceutical innovations with regard to therapeutic advantage. | BMC clinical pharmacology 20100101 |
| First qualification study of serum biomarkers as indicators of total body burden of osteoarthritis. | PloS one 20100101 |
| The association between subchondral bone cysts and tibial cartilage volume and risk of joint replacement in people with knee osteoarthritis: a longitudinal study. | Arthritis research & therapy 20100101 |
| Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study. | BMC musculoskeletal disorders 20100101 |
| Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial. | Breast cancer research : BCR 20100101 |
| Incidence and mortality of hip fracture among the elderly population in South Korea: a population-based study using the national health insurance claims data. | BMC public health 20100101 |
| Alendronate improves QOL of postmenopausal women with osteoporosis. | Clinical interventions in aging 20100101 |
| Accelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritis. | Arthritis research & therapy 20100101 |
| Five-year follow-up of Japanese patients with Paget's disease of the bone after treatment with low-dose oral alendronate: a case series. | Journal of medical case reports 20100101 |
| Alterations in osteoclast function and phenotype induced by different inhibitors of bone resorption--implications for osteoclast quality. | BMC musculoskeletal disorders 20100101 |
| Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis. | Therapeutics and clinical risk management 20100101 |
| [Osteoporosis in men]. | Revista clinica espanola 20100101 |
| Low-level vibrations retain bone marrow's osteogenic potential and augment recovery of trabecular bone during reambulation. | PloS one 20100101 |
| Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition. | Breast cancer research : BCR 20100101 |
| Strategies for strengthening patent protection of pharmaceutical inventions in light of federal court decisions. | Current topics in medicinal chemistry 20100101 |
| Inhibition of the progesterone nuclear receptor during the bone linear growth phase increases peak bone mass in female mice. | PloS one 20100101 |
| The delivery of evidence-based preventive care for older Americans with arthritis. | Arthritis research & therapy 20100101 |
| Challenges in clinical patient management. | Cancer investigation 20100101 |
| Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis. | Therapeutics and clinical risk management 20100101 |
| Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis. | Patient preference and adherence 20100101 |
| The correlation of osteoporosis to clinical features: a study of 4382 female cases of a hospital cohort with musculoskeletal symptoms in southwest China. | BMC musculoskeletal disorders 20100101 |
| Managing bone health in women with breast cancer under adjuvant treatment with aromatase inhibitors: pretreatment bone mineral density is important. | Breast cancer research : BCR 20100101 |
| The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation. | Arthritis research & therapy 20100101 |
| Community based intervention to optimize osteoporosis management: randomized controlled trial. | BMC geriatrics 20100101 |
| Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort. | BMJ (Clinical research ed.) 20100101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20100101 |
| Development of an ion-pair reversed-phase HPLC method with indirect UV detection for determination of phosphates and phosphites as impurities in sodium risedronate. | Journal of AOAC International 20100101 |
| Development and validation of a micellar high-performance liquid chromatographic method for determination of risedronate in raw material and in a pharmaceutical formulation: application to stability studies. | Journal of AOAC International 20100101 |
| Aging, human immunodeficiency virus, and bone health. | Clinical interventions in aging 20100101 |
| Risedronate therapy for the prevention of steroid-induced osteoporosis in patients with minimal-change nephrotic syndrome. | Internal medicine (Tokyo, Japan) 20100101 |
| Absorption of silicon from artesian aquifer water and its impact on bone health in postmenopausal women: a 12 week pilot study. | Nutrition journal 20100101 |
| Current and developing therapeutic agents in the treatment of Chagas disease. | Drug design, development and therapy 20100101 |
| Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on long-term glucocorticoid. | Arthritis research & therapy 20100101 |
| A systematic review of the effectiveness of interventions to improve post-fracture investigation and management of patients at risk of osteoporosis. | Implementation science : IS 20100101 |
| A radiographic study on the associations of age and prevalence of vertebral fractures with abdominal aortic calcification in Japanese postmenopausal women and men. | Journal of osteoporosis 20100101 |
| Role of teriparatide in treatment of glucocorticoid-induced osteoporosis. | Therapeutics and clinical risk management 20100101 |
| Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal. | International journal of women's health 20100101 |
| Profile of teriparatide in the management of postmenopausal osteoporosis. | International journal of women's health 20100101 |
| Mutually exclusive expression of DLX2 and DLX5/6 is associated with the metastatic potential of the human breast cancer cell line MDA-MB-231. | BMC cancer 20100101 |
| The association between hip fracture and hip osteoarthritis: a case-control study. | BMC musculoskeletal disorders 20100101 |
| Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass. | Drug design, development and therapy 20100101 |
| Zoledronic acid infusion for prevention and treatment of osteoporosis. | International journal of women's health 20100101 |
| Prevention of bone metastases and management of bone health in early breast cancer. | Breast cancer research : BCR 20100101 |
| Pharmacogenetics of osteoporosis. | F1000 biology reports 20100101 |
| Anti-tumour activity of bisphosphonates in preclinical models of breast cancer. | Breast cancer research : BCR 20100101 |
| Characterization of a rat model of metastatic prostate cancer bone pain. | Journal of pain research 20100101 |
| Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures. | Therapeutics and clinical risk management 20100101 |
| The ARF tumor suppressor regulates bone remodeling and osteosarcoma development in mice. | PloS one 20100101 |
| Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary. | Clinical interventions in aging 20100101 |
| Protective effect of hypoxia on bisphosphonate‑related bone cell damage. | Molecular medicine reports 20100101 |
| Intravenous bisphosphonates for postmenopausal osteoporosis. | Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 20100101 |
| catena-Poly[zinc(II)-μ(3)-{hydrogen [1-hydr-oxy-2-(3-pyridinio)ethane-1,1-di-yl]diphospho-nato}]. | Acta crystallographica. Section E, Structure reports online 20100101 |
| Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options. | Drug, healthcare and patient safety 20100101 |
| Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management. | Drug, healthcare and patient safety 20100101 |
| Risedronate's efficacy: from randomized clinical trials to real clinical practice. | Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases 20100101 |
| Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis. | Rheumatology international 20091201 |
| Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150 mg and risedronate 150 mg. | Current medical research and opinion 20091201 |
| Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases. | International journal of clinical practice 20091201 |
| Correlation between serum C-terminal cross-linking telopeptide of type I collagen and staging of oral bisphosphonate-related osteonecrosis of the jaws. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20091201 |
| Review of osteoporosis pharmacotherapy for geriatric patients. | The American journal of geriatric pharmacotherapy 20091201 |
| Hemorrhage from a pituitary macroadenoma after a minor trauma. | Journal of clinical medicine research 20091201 |
| Synergistic effect of bisphosphonate and docetaxel on the growth of bone metastasis in an animal model of established metastatic bone disease. | Breast cancer research and treatment 20091101 |
| Effects of PTH treatment on tibial bone of ovariectomized rats assessed by in vivo micro-CT. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20091101 |
| Prior treatment with vitamin K(2) significantly improves the efficacy of risedronate. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20091101 |
| Risedronate dosing before breakfast compared with dosing later in the day in women with postmenopausal osteoporosis. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20091101 |
| Comparison of monthly ibandronate versus weekly risedronate in preference, convenience, and bone turnover markers in Korean postmenopausal osteoporotic women. | Calcified tissue international 20091101 |
| A retrospective clinical and radiographic study on healing of periradicular lesions in patients taking oral bisphosphonates. | Journal of endodontics 20091101 |
| Adjuvant bisphosphonates in endocrine-responsive breast cancer: what is their place in therapy? | Therapeutic advances in medical oncology 20091101 |
| Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20091001 |
| Comparative gastrointestinal safety of weekly oral bisphosphonates. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20091001 |
| Treating osteoporosis in Canada: what clinical efficacy data should be considered by policy decision makers? | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20091001 |
| Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using (41)Ca methodology. | The Journal of clinical endocrinology and metabolism 20091001 |
| Nanostructured polyelectrolyte multilayer drug delivery systems for bone metastasis prevention. | Biomaterials 20091001 |
| Combination of nanoindentation and quantitative backscattered electron imaging revealed altered bone material properties associated with femoral neck fragility. | Calcified tissue international 20091001 |
| Loss of life years after a hip fracture. | Acta orthopaedica 20091001 |
| Comparison of direct health care costs related to the pharmacological treatment of osteoporosis and to the management of osteoporotic fractures among compliant and noncompliant users of alendronate and risedronate: a population-based study. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090901 |
| Cancer-induced bone loss and associated pain-related behavior is reduced by risedronate but not its phosphonocarboxylate analog NE-10790. | International journal of cancer 20090901 |
| Re 'Effect of long-term treatment with risedronate on arterial compliance in osteoporotic patients with cardiovascular risk factors' by A. Luckish et al. | Bone 20090901 |
| Clinical and therapeutic aspects of osteoporosis. | European journal of radiology 20090901 |
| Vitamin K to prevent fractures in older women: systematic review and economic evaluation. | Health technology assessment (Winchester, England) 20090901 |
| Comparison of the effects of alendronate and alfacalcidol on hip bone mineral density and bone turnover in Japanese men having osteoporosis or osteopenia with clinical risk factors for fractures. | Yonsei medical journal 20090831 |
| Differences in persistence among different weekly oral bisphosphonate medications. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090801 |
| Determination of rat vertebral bone compressive fatigue properties in untreated intact rats and zoledronic-acid-treated, ovariectomized rats. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090801 |
| Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090801 |
| Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a meta-analysis. | Breast cancer research and treatment 20090801 |
| Prevention of vertebral fractures in osteoporosis: mixed treatment comparison of bisphosphonate therapies. | Current medical research and opinion 20090801 |
| Weekly versus monthly drug regimens: 1-year compliance and persistence with bisphosphonate therapy. | Current medical research and opinion 20090801 |
| [Biochemical markers of bone turnover. New aspect. Biochemical markers of bone turnover in long term treatment with bisphosphonate]. | Clinical calcium 20090801 |
| Corticosteroids: no drug prevention of fractures needed. | Prescrire international 20090801 |
| Effects of risedronate on bone turnover markers in osteoporotic postmenopausal women: comparison of two protocols of treatment. | La Tunisie medicale 20090801 |
| Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats. | Maturitas 20090720 |
| Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090701 |
| New suggestions for the mechanical control of bone remodeling. | Calcified tissue international 20090701 |
| The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090701 |
| Risedronate directly inhibits osteoclast differentiation and inflammatory bone loss. | Biological & pharmaceutical bulletin 20090701 |
| [Acute exacerbation of a chronic esophagitis]. | Deutsche medizinische Wochenschrift (1946) 20090701 |
| Safety of adjuvant endocrine therapies in hormone receptor-positive early breast cancer. | Current oncology (Toronto, Ont.) 20090701 |
| The effect of risedronate on posterior lateral spinal fusion in a rat model. | Journal of Korean Neurosurgical Society 20090701 |
| DXA-based hip structural analysis of once-weekly bisphosphonate-treated postmenopausal women with low bone mass. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090601 |
| Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090601 |
| RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090601 |
| Bone microdamage. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090601 |
| Risedronate recovers bone loss in patients with prostate cancer undergoing androgen-deprivation therapy. | Urology 20090601 |
| Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090601 |
| Synergistic action of statins and nitrogen-containing bisphosphonates in the development of rhabdomyolysis in L6 rat skeletal myoblasts. | The Journal of pharmacy and pharmacology 20090601 |
| Effects of risedronate on bone turnover markers in osteoporotic postmenopausal women: comparison of two protocols of treatment. | La Tunisie medicale 20090601 |
| Theoretical analysis of alendronate and risedronate effects on canine vertebral remodeling and microdamage. | Journal of biomechanics 20090511 |
| Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence. | Bone 20090501 |
| Risk of fracture in women treated with monthly oral ibandronate or weekly bisphosphonates: the eValuation of IBandronate Efficacy (VIBE) database fracture study. | Bone 20090501 |
| Improved GI tolerability with monthly ibandronate in women previously using weekly bisphosphonates. | Southern medical journal 20090501 |
| Osteonecrosis associated with short-term oral administration of bisphosphonate. | The Journal of prosthetic dentistry 20090501 |
| Necrotic actions of nitrogen-containing bisphosphonates and their inhibition by clodronate, a non-nitrogen-containing bisphosphonate in mice: potential for utilization of clodronate as a combination drug with a nitrogen-containing bisphosphonate. | Basic & clinical pharmacology & toxicology 20090501 |
| [Risedronate for treatment of osteoporosis]. | Nihon rinsho. Japanese journal of clinical medicine 20090501 |
| [A-TOP research group/JOINT program]. | Nihon rinsho. Japanese journal of clinical medicine 20090501 |
| Evaluating the antifracture efficacy of bisphosphonates. | Reviews on recent clinical trials 20090501 |
| Hip fracture in a patient affected by transient osteoporosis of the femoral head during the last trimester of pregnancy. | Orthopedics 20090501 |
| Comparison of the effect of vitamin K(2) and risedronate on trabecular bone in glucocorticoid-treated rats: a bone histomorphometry study. | Yonsei medical journal 20090430 |
| Glucocorticoid-induced osteoporosis: hope on the HORIZON. | Lancet (London, England) 20090411 |
| Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial. | Lancet (London, England) 20090411 |
| Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090401 |
| Bone structure and remodelling in stroke patients: early effects of zoledronate. | Bone 20090401 |
| Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone. | Bone 20090401 |
| Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronate. | The Annals of pharmacotherapy 20090401 |
| Comparison of radiographic fracture healing in the distal radius for patients on and off bisphosphonate therapy. | The Journal of hand surgery 20090401 |
| Prevention of glucocorticoid-induced osteoporosis. | Expert opinion on pharmacotherapy 20090401 |
| Phosphonocarboxylates inhibit the second geranylgeranyl addition by Rab geranylgeranyl transferase. | The Journal of biological chemistry 20090313 |
| [Postmenopausal osteoporosis. Bisphosphonates are not all equal]. | MMW Fortschritte der Medizin 20090312 |
| [Patient compliance program aids therapy success]. | MMW Fortschritte der Medizin 20090312 |
| Effects of suppression of bone turnover on cortical and trabecular load sharing in the canine vertebral body. | Journal of biomechanics 20090311 |
| Effect of risedronate in a minipig cartilage defect model with allograft. | Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20090301 |
| Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090301 |
| LRP5 Polymorphisms and response to risedronate treatment in osteoporotic men. | Calcified tissue international 20090301 |
| Dental implants in a patient with Paget disease under bisphosphonate treatment: a case report. | Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20090301 |
| Transcriptome and proteome analysis of osteocytes treated with nitrogen-containing bisphosphonates. | Journal of proteome research 20090301 |
| Generalized arterial calcification of infancy: treatment with bisphosphonates. | Nature clinical practice. Endocrinology & metabolism 20090301 |
| Bisphosphonates for postmenopausal osteoporosis: determining duration of treatment. | Current osteoporosis reports 20090301 |
| Assessment of bone quality using finite element analysis based upon micro-CT images. | Clinics in orthopedic surgery 20090301 |
| A sensitive post-column photochemical derivatization/fluorimetric detection system for HPLC determination of bisphosphonates. | Journal of chromatography. A 20090227 |
| Vitamin D status and response to treatment in post-menopausal osteoporosis. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090201 |
| Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090201 |
| Reduced COX-2 expression in aged mice is associated with impaired fracture healing. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090201 |
| Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis. | The American journal of medicine 20090201 |
| New findings with old drugs for osteoporosis. | Expert opinion on pharmacotherapy 20090201 |
| Monaural diplacusis with tinnitus, aural fullness, hyperacusis, and sensorineural hearing loss. | Ear, nose, & throat journal 20090201 |
| Comparison of the effects of once-monthly versus once-daily risedronate in postmenopausal osteoporosis: a phase II, 6-month, multicenter, randomized, double-blind, active-controlled, dose-ranging study. | Clinical therapeutics 20090201 |
| Paget's disease 2: exploring diagnosis, management and support strategies. | Nursing times 20090201 |
| [Osteoporosis]. | Revue medicale suisse 20090114 |
| Changes of the quality-of-life under the treatment of severe senile osteoporosis with teriparatide. | Archives of gerontology and geriatrics 20090101 |
| Bisphosphonate therapy ameliorates hearing loss in mice lacking osteoprotegerin. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090101 |
| Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study. | Rheumatology international 20090101 |
| The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates. | QJM : monthly journal of the Association of Physicians 20090101 |
| Effects of short-term risedronate on bone resorption and patient satisfaction in postmenopausal osteoporosis patients. | Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20090101 |
| Analysis of factors affecting increase in bone mineral density at lumbar spine by bisphosphonate treatment in postmenopausal osteoporosis. | Journal of bone and mineral metabolism 20090101 |
| [New development in bisphosphonate treatment. Fracture prevention by bisphosphonates]. | Clinical calcium 20090101 |
| [New development in bisphosphonate treatment. Characteristics and effectiveness of intermittent bisphophonates]. | Clinical calcium 20090101 |
| [New development in bisphosphonate treatment. When and how long should patients take bisphosphonates for osteoporosis?]. | Clinical calcium 20090101 |
| Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club. | International journal of clinical practice 20090101 |
| Zoledronic acid in metastatic chondrosarcoma and advanced sacrum chordoma: two case reports. | Journal of experimental & clinical cancer research : CR 20090101 |
| New bisphosphonates and trends in drug therapy for osteoporosis: preface. | Clinical calcium 20090101 |
| [Examination of beneficial effects of risedronate in improving quality of life during long-term treatment of primary osteoporosis]. | Nihon rinsho. Japanese journal of clinical medicine 20090101 |
| Effects of risedronate or alfacalcidol on bone mineral density, bone turnover, back pain, and fractures in Japanese men with primary osteoporosis: results of a two-year strict observational study. | Journal of bone and mineral metabolism 20090101 |
| Comparison of the analgesic effects of bisphosphonates: etidronate, alendronate and risedronate by electroalgometry utilizing the fall of skin impedance. | Journal of bone and mineral metabolism 20090101 |
| Oral bisphosphonates and risk of atrial fibrillation and flutter in women: a self-controlled case-series safety analysis. | PloS one 20090101 |
| Preventing nonvertebral osteoporotic fractures with extended-interval bisphosphonates: regimen selection and clinical application. | Medscape journal of medicine 20090101 |
| The effect of risedronate treatment on serum cytokines in postmenopausal osteoporosis: a 6-month randomized and controlled study. | Journal of bone and mineral metabolism 20090101 |
| Heterotopic ossification in systemic sclerosis. | Scandinavian journal of rheumatology 20090101 |
| Value of a new fixed-combination pack of bisphosphonate, calcium and vitamin D in the therapy of osteoporosis: results of two quantitative patient research studies. | Drugs & aging 20090101 |
| Anti-fracture efficacy of risedronic acid in men: A meta-analysis of randomized controlled trials. | Clinical drug investigation 20090101 |
| Anti-osteoporotic treatments in neurological diseases. | Functional neurology 20090101 |
| RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro. | Arthritis research & therapy 20090101 |
| Biphosphonates-related osteonecrosis of the jaw: Clinical and physiopathological considerations. | Therapeutics and clinical risk management 20090101 |
| Risedronate on two consecutive days per month. | Drugs & aging 20090101 |
| [Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009]. | Wiener medizinische Wochenschrift. Supplement 20090101 |
| Developments in the scientific understanding of osteoporosis. | Arthritis research & therapy 20090101 |
| Effect of an isoflavones-containing red clover preparation and alkaline supplementation on bone metabolism in ovariectomized rats. | Clinical interventions in aging 20090101 |
| Diagnosis and management of osteoporosis in the older senior. | Clinical interventions in aging 20090101 |
| Once-yearly zoledronic acid in hip fracture prevention. | Clinical interventions in aging 20090101 |
| Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis. | Clinical interventions in aging 20090101 |
| Raloxifene: mechanism of action, effects on bone tissue, and applicability in clinical traumatology practice. | The open orthopaedics journal 20090101 |
| Developments in the scientific understanding of osteoarthritis. | Arthritis research & therapy 20090101 |
| The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis. | BMC musculoskeletal disorders 20090101 |
| Management of glucocorticoids-induced osteoporosis: role of teriparatide. | Therapeutics and clinical risk management 20090101 |
| Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture. | Therapeutics and clinical risk management 20090101 |
| Use of risk stratification to target therapies in patients with recent onset arthritis; design of a prospective randomized multicenter controlled trial. | BMC musculoskeletal disorders 20090101 |
| Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data. | BMJ (Clinical research ed.) 20090101 |
| Bisphosphonate-associated adverse events. | Hormones (Athens, Greece) 20090101 |
| Closing the osteoporosis care gap: increased osteoporosis awareness among geriatrics and rehabilitation teams. | BMC geriatrics 20090101 |
| Treatment with intravenous pamidronate is a good alternative in case of gastrointestinal side effects or contraindications for oral bisphosphonates. | BMC musculoskeletal disorders 20090101 |
| Risedronate inhibits human osteosarcoma cell invasion. | Journal of experimental & clinical cancer research : CR 20090101 |
| Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers. | Arthritis research & therapy 20090101 |
| The utilization of appropriate osteoporosis medications improves following a multifaceted educational intervention: the Canadian quality circle project (CQC). | BMC medical education 20090101 |
| Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs. | Interdisciplinary perspectives on infectious diseases 20090101 |
| Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis. | Therapeutics and clinical risk management 20090101 |
| Management strategies for pulmonary sarcoidosis. | Therapeutics and clinical risk management 20090101 |
| Identification of secondary targets of N-containing bisphosphonates in mammalian cells via parallel competition analysis of the barcoded yeast deletion collection. | Genome biology 20090101 |
| Targeted treatment in COPD: a multi-system approach for a multi-system disease. | International journal of chronic obstructive pulmonary disease 20090101 |
| Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies. | BMC musculoskeletal disorders 20090101 |
| Profound muscle weakness and pain after one dose of actonel. | Case reports in medicine 20090101 |
| Osteoporosis in children: pediatric and pediatric rheumatology perspective: a review. | Pediatric rheumatology online journal 20090101 |
| Progress in osteoporosis and fracture prevention: focus on postmenopausal women. | Arthritis research & therapy 20090101 |
| Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment. | Clinical interventions in aging 20090101 |
| Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis. | Therapeutics and clinical risk management 20090101 |
| Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases. | Drug design, development and therapy 20090101 |
| Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. | BMJ (Clinical research ed.) 20090101 |
| Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis. | Patient preference and adherence 20090101 |
| Circumferential thoracolumbar corrective fusion with an anterior interbody fresh-frozen femoral head allograft for osteoporotic lower acute kyphosis: a case report. | Journal of medical case reports 20090101 |
| Prevention of hip fractures by exposure to sunlight and pharmacotherapy in patients with Alzheimer's disease. | Aging clinical and experimental research 20090101 |
| Reducing hip fracture risk with risedronate in elderly women with established osteoporosis. | Clinical interventions in aging 20090101 |
| A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis. | Arthritis research & therapy 20090101 |
| Evaluation of the effect of 4 months of risedronate therapy on femoral strength using femoral strength analysis tools. | The Journal of international medical research 20090101 |
| Osteoporosis: 'A risk factor for periodontitis'. | Journal of Indian Society of Periodontology 20090101 |
| The response to oestrogen deprivation of the cartilage collagen degradation marker, CTX-II, is unique compared with other markers of collagen turnover. | Arthritis research & therapy 20090101 |
| The evolving role of zoledronic acid in early breast cancer. | OncoTargets and therapy 20090101 |
| Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect. | Core evidence 20090101 |
| Lasofoxifene: Evidence of its therapeutic value in osteoporosis. | Core evidence 20090101 |
| Recent advances in managing osteoporosis. | F1000 medicine reports 20090101 |
| Once-monthly risedronate for postmenopausal osteoporosis. | International journal of women's health 20090101 |
| Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update. | International journal of women's health 20090101 |
| Treating postmenopausal osteoporosis in women at increased risk of fracture - critical appraisal of bazedoxifene: a review. | International journal of women's health 20090101 |
| Update on the efficacy, safety, and adherence to treatment of full length parathyroid hormone, PTH (1-84), in the treatment of postmenopausal osteoporosis. | International journal of women's health 20090101 |
| Pharmacotherapeutic options for visceral leishmaniasis-current scenario. | Clinical medicine. Pathology 20090101 |
| [Primary hypertrophic osteoarthropathy (pachydermoperiostosis). Report of two familial cases and literature review]. | Reumatologia clinica 20090101 |
| A label-free electronic biosensor for detection of bone turnover markers. | Sensors (Basel, Switzerland) 20090101 |
| Teriparatide treatment in adult hypophosphatasia in a patient exposed to bisphosphonate: a case report. | Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases 20090101 |
| Targeting a uniquely nonspecific prenyl synthase with bisphosphonates to combat cryptosporidiosis. | Chemistry & biology 20081222 |
| Geranylgeranyl transferase type II inhibition prevents myeloma bone disease. | Biochemical and biophysical research communications 20081212 |
| Effect of temporal changes in bone turnover on the bone mineralization density distribution: a computer simulation study. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20081201 |
| A new dinuclear platinum complex with a nitrogen-containing geminal bisphosphonate as potential anticancer compound specifically targeted to bone tissues. | Journal of inorganic biochemistry 20081201 |
| Osteoporosis: how long should we treat? | Current opinion in endocrinology, diabetes, and obesity 20081201 |
| [Non traumatic tooth extraction in patients treated by bisphosphonate]. | Revue de stomatologie et de chirurgie maxillo-faciale 20081201 |
| Fluorescently labeled risedronate and related analogues: 'magic linker' synthesis. | Bioconjugate chemistry 20081201 |
| Evaluation by digital subtraction radiography of induced changes in the bone density of the female rat mandible. | Dento maxillo facial radiology 20081201 |
| Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations. | Clinical interventions in aging 20081201 |
| Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment. | Clinical interventions in aging 20081201 |
| Bazedoxifene for the prevention of postmenopausal osteoporosis. | Therapeutics and clinical risk management 20081201 |
| Denosumab: an investigational drug for the management of postmenopausal osteoporosis. | Biologics : targets & therapy 20081201 |
| Kinetic study on hemipenta hydrate risedronate monosodium in batch crystallization by cooling mode. | International journal of pharmaceutics 20081119 |
| Compatibility of risedronate sodium tablets with food thickeners. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20081115 |
| Determination of bisphosphonate active pharmaceutical ingredients in pharmaceuticals and biological material: a review of analytical methods. | Journal of pharmaceutical and biomedical analysis 20081104 |
| How stress fracture incidence was lowered in the Israeli army: a 25-yr struggle. | Medicine and science in sports and exercise 20081101 |
| Lowering bone mineral affinity of bisphosphonates as a therapeutic strategy to optimize skeletal tumor growth inhibition in vivo. | Cancer research 20081101 |
| Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization. | Arthritis and rheumatism 20081101 |
| The correlation between phalangeal quantitative ultrasonography and dual energy x-ray absorptiometry in women with premature ovarian failure. | McGill journal of medicine : MJM : an international forum for the advancement of medical sciences by students 20081101 |
| Effects of risedronate in a rat model of osteopenia due to orchidectomy and disuse: densitometric, histomorphometric and microtomographic studies. | Micron (Oxford, England : 1993) 20081001 |
| Impact of compliance and persistence with bisphosphonate therapy on health care costs and utilization. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20081001 |
| Recovery of trabecular and cortical bone turnover after discontinuation of risedronate and alendronate therapy in ovariectomized rats. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20081001 |
| Fracture outcomes related to persistence and compliance with oral bisphosphonates. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20081001 |
| Identification of material parameters based on Mohr-Coulomb failure criterion for bisphosphonate treated canine vertebral cancellous bone. | Bone 20081001 |
| [Guidelines for the management of osteoporosis]. | Der Internist 20081001 |
| How effective is risedronate in preventing bone loss in patients on high-dose steroids? | Nature clinical practice. Endocrinology & metabolism 20081001 |
| Cutaneous vasculitis induced by risedronate. | Allergy 20081001 |
| Low incidence of anti-osteoporosis treatment after hip fracture. | The Journal of bone and joint surgery. American volume 20081001 |
| [Efficacy and tolerability of risedronate for the treatment of osteoporosis]. | Clinical calcium 20081001 |
| [Evidence and utility of etidronate for the treatment of osteoporosis]. | Clinical calcium 20081001 |
| Effects of risedronate on alveolar bone loss and angiogenesis: a stereologic study in rats. | Journal of periodontology 20081001 |
| Paget disease of bone: therapeutic options. | Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20081001 |
| [Treatment of osteoporosis in the elderly: what is the evidence?]. | Tijdschrift voor gerontologie en geriatrie 20081001 |
| Osteoporosis and osteoporotic fracture occurrence and prevention in the elderly: a geriatric perspective. | Best practice & research. Clinical endocrinology & metabolism 20081001 |
| [Progress in the treatment of osteoporosis]. | Rinsho byori. The Japanese journal of clinical pathology 20081001 |
| Risedronic acid: new indication. No fewer symptomatic fractures in men. | Prescrire international 20081001 |
| [Severe oesophagus injury as a complication during treatment with risedronic acid]. | Nederlands tijdschrift voor geneeskunde 20080927 |
| Monthly risedronate (Actonel) for postmenopausal osteoporosis. | The Medical letter on drugs and therapeutics 20080908 |
| Oral nitrogen-containing bisphosphonates: a systematic review of randomized clinical trials and vertebral fractures. | Current medical research and opinion 20080901 |
| Determinants of persistence with weekly bisphosphonates in patients with osteoporosis. | The Journal of rheumatology 20080901 |
| Nonvertebral fracture risk reduction with nitrogen-containing bisphosphonates. | Current osteoporosis reports 20080901 |
| IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole. | Expert review of anticancer therapy 20080901 |
| Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations. | The American journal of managed care 20080901 |
| Changes in urinary NTX levels in patients with primary osteoporosis undergoing long-term bisphosphonate treatment. | Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20080901 |
| [Update on treatment of postmenopausal osteoporosis]. | Revue medicale de Bruxelles 20080901 |
| Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women. | Clinical interventions in aging 20080901 |
| Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature. | Clinical interventions in aging 20080901 |
| Osteoporosis in men. | The New England journal of medicine 20080821 |
| Osteoporosis treatment and fracture incidence: the ICARO longitudinal study. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080801 |
| Using nurses and office staff to report prescribing errors in primary care. | International journal for quality in health care : journal of the International Society for Quality in Health Care 20080801 |
| Effect of long-term treatment with risedronate on arterial compliance in osteoporotic patients with cardiovascular risk factors. | Bone 20080801 |
| Effect of risedronate on hip structural geometry: a 1-year, double-blind trial in chemotherapy-induced postmenopausal women. | Bone 20080801 |
| Effects of vitamin K(2) and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats. | Calcified tissue international 20080801 |
| Maximizing effectiveness of bisphosphonate therapy for osteoporosis. | Southern medical journal 20080801 |
| Potential excessive suppression of bone turnover with long-term oral bisphosphonate therapy in postmenopausal osteoporotic patients. | Climacteric : the journal of the International Menopause Society 20080801 |
| The diagnosis and treatment of primary osteoporosis according to current guidelines. | Deutsches Arzteblatt international 20080801 |
| Determination of the microscopic equilibrium dissociation constants for risedronate and its analogues reveals two distinct roles for the nitrogen atom in nitrogen-containing bisphosphonate drugs. | Journal of medicinal chemistry 20080724 |
| Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080701 |
| Patients' preferences for osteoporosis drug treatment: a discrete choice experiment. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080701 |
| Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women. | British journal of clinical pharmacology 20080701 |
| Advanced CT bone imaging in osteoporosis. | Rheumatology (Oxford, England) 20080701 |
| Effects of combined administration of alfacalcidol and risedronate on cancellous and cortical bone mass of the tibia in glucocorticoid-treated young rats. | The Chinese journal of physiology 20080630 |
| Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolution in vitro. | Journal of biomedical materials research. Part A 20080615 |
| Risks and benefits of bisphosphonates. | British journal of cancer 20080603 |
| Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial. | Osteoarthritis and cartilage 20080601 |
| Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080601 |
| The use of bisphosphonate in the treatment of avascular necrosis: a systematic review. | Clinical rheumatology 20080601 |
| Treatment of Paget's disease of bone: a survey of clinical practice in Australia. | Bone 20080601 |
| Head-to-head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial. | International journal of clinical practice 20080601 |
| Risedronate prevents bone loss in breast cancer survivors: a 2-year, randomized, double-blind, placebo-controlled clinical trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080601 |
| Secondary osteoporosis in long-term bedridden patients with cerebral palsy. | Pediatrics international : official journal of the Japan Pediatric Society 20080601 |
| 7-ketocholesterol, a major oxysterol, promotes pi-induced vascular calcification in cultured smooth muscle cells. | Journal of atherosclerosis and thrombosis 20080601 |
| Risedronic acid and calcium + colecalciferol: new combination. A simple combination of two other products. A simple commercial ploy with no benefit for patients. | Prescrire international 20080601 |
| Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis. | Clinical interventions in aging 20080601 |
| Bisphosphonates in the management of postmenopausal osteoporosis--optimizing efficacy in clinical practice. | Clinical interventions in aging 20080601 |
| Clinical challenges in the management of osteoporosis. | Clinical interventions in aging 20080601 |
| Summaries for patients. Drug therapy for osteoporosis. | Annals of internal medicine 20080506 |
| Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture. | Annals of internal medicine 20080506 |
| Correlation between bone lesion changes and cartilage volume loss in patients with osteoarthritis of the knee as assessed by quantitative magnetic resonance imaging over a 24-month period. | Annals of the rheumatic diseases 20080501 |
| Synthesis, properties, and perspectives of gem-diphosphono substituted-thiazoles. | European journal of medicinal chemistry 20080501 |
| Effects of risedronate on fracture risk in postmenopausal women with osteopenia. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080501 |
| Greater first year effectiveness drives favorable cost-effectiveness of brand risedronate versus generic or brand alendronate: modeled Canadian analysis. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080501 |
| Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells. | Bone 20080501 |
| Determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosis. | Current medical research and opinion 20080501 |
| Efficacy of risedronate against hip fracture in patients with neurological diseases: a meta-analysis of randomized controlled trials. | Current medical research and opinion 20080501 |
| Biomarkers of bone health and osteoporosis risk. | The Proceedings of the Nutrition Society 20080501 |
| Farnesyl pyrophosphate synthase enantiospecificity with a chiral risedronate analog, [6,7-dihydro-5H-cyclopenta[c]pyridin-7-yl(hydroxy)methylene]bis(phosphonic acid) (NE-10501): Synthetic, structural, and modeling studies. | Bioorganic & medicinal chemistry letters 20080501 |
| Raloxifene has favourable effects on metabolic parameters but has no effect on left ventricular function in postmenopausal women. | Pharmacological research 20080501 |
| Esophageal transit and in vivo disintegration of branded risedronate sodium tablets and two generic formulations of alendronic acid tablets: a single-center, single-blind, six-period crossover study in healthy female subjects. | Clinical therapeutics 20080501 |
| Can a disorder of the vestibular system underlie an etiology for migraine? | Ear, nose, & throat journal 20080501 |
| Osteoporotic fracture management in India: a survey of orthopaedic surgeons. | Journal of the Indian Medical Association 20080501 |
| Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase. | Journal of medicinal chemistry 20080410 |
| Loss of treatment benefit due to low compliance with bisphosphonate therapy. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080401 |
| Use of oral bisphosphonates and the risk of aseptic osteonecrosis: a nested case-control study. | The Journal of rheumatology 20080401 |
| European guidance for the diagnosis and management of osteoporosis in postmenopausal women. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080401 |
| Serum osteoprotegerin and RANKL are not specifically altered in women with postmenopausal osteoporosis treated with teriparatide or risedronate: a randomized, controlled trial. | Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20080401 |
| FRAX and the assessment of fracture probability in men and women from the UK. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080401 |
| A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-International. | International journal of clinical practice 20080401 |
| In vitro disintegration and dissolution studies of once-weekly copies of alendronate sodium tablets (70 mg) and in vivo implications. | Current medical research and opinion 20080401 |
| Effect of risedronate on biochemical marker of bone resorption in postmenopausal women with osteoporosis or osteopenia. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20080401 |
| Osteonecrosis of the jaw: new developments in an old disease. | The Journal of rheumatology 20080401 |
| 3-year results of a member and physician intervention to reduce risk associated with glucocorticoid-induced osteoporosis in a health plan. | Journal of managed care pharmacy : JMCP 20080401 |
| Increase in bone mass after correction of vitamin D insufficiency in bisphosphonate-treated patients. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20080401 |
| Adherence to and gastrointestinal tolerability of monthly oral or quarterly intravenous ibandronate therapy in women with previous intolerance to oral bisphosphonates: a 12-month, open-label, prospective evaluation. | Clinical therapeutics 20080401 |
| Use of ibandronate in the prevention of skeletal events in metastatic breast cancer. | Therapeutics and clinical risk management 20080401 |
| Fracture risk remains reduced one year after discontinuation of risedronate. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080301 |
| Risedronate reduces osteoclast precursors and cytokine production in postmenopausal osteoporotic women. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20080301 |
| Risedronate for prevention of bone mineral density loss in patients receiving high-dose glucocorticoids: a randomized double-blind placebo-controlled trial. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080301 |
| Preservation of periarticular cancellous morphology and mechanical stiffness in post-traumatic experimental osteoarthritis by antiresorptive therapy. | Clinical biomechanics (Bristol, Avon) 20080301 |
| Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080301 |
| Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis. | The Journal of clinical endocrinology and metabolism 20080301 |
| A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg. | Current medical research and opinion 20080301 |
| Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results. | The Journal of rheumatology 20080301 |
| Bone degeneration and recovery after early and late bisphosphonate treatment of ovariectomized wistar rats assessed by in vivo micro-computed tomography. | Calcified tissue international 20080301 |
| [Variance of expressions of extracellular matrix components and effects of anti-osteoporotic drugs on Mönckeberg's arteriosclerosis]. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20080301 |
| Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment. | Clinical therapeutics 20080301 |
| Intravenous zoledronic acid for the treatment of osteoporosis. | Current osteoporosis reports 20080301 |
| Raloxifene for older women: a review of the literature. | Clinical interventions in aging 20080301 |
| Vertebroplasty and kyphoplasty: a comparative review of efficacy and adverse events. | Current reviews in musculoskeletal medicine 20080301 |
| Incidence of fracture in adjacent levels in patients treated with balloon kyphoplasty: a review of the literature. | Current reviews in musculoskeletal medicine 20080301 |
| Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. | Annals of internal medicine 20080205 |
| [Radius shaft fracture in a 31-year old man]. | Revista clinica espanola 20080201 |
| The utilisation and expenditure of medicines for the prophylaxis and treatment of osteoporosis. | Irish medical journal 20080201 |
| NMR investigations of the static and dynamic structures of bisphosphonates on human bone: a molecular model. | Journal of the American Chemical Society 20080130 |
| Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. | The Cochrane database of systematic reviews 20080123 |
| [Trends in osteoporosis]. | Revue medicale suisse 20080116 |
| Changes in vertebral strength-density and energy absorption-density relationships following bisphosphonate treatment in beagle dogs. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080101 |
| Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis. | Bone 20080101 |
| Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080101 |
| Non-vertebral fracture risk reduction with oral bisphosphonates: challenges with interpreting clinical trial data. | Current medical research and opinion 20080101 |
| The cost-effectiveness of risedronate treatment in Japanese women with osteoporosis. | Journal of bone and mineral metabolism 20080101 |
| Assessing the relative efficacy of different agents based on the outcomes from meta-analyses. | International journal of clinical practice 20080101 |
| Extracellular calcium increases bisphosphonate-induced growth inhibition of breast cancer cells. | Breast cancer research : BCR 20080101 |
| [Patient's preference for the daily and weekly bisphosphonate--evaluation from questionnaire of osteoporosis patients]. | Nihon rinsho. Japanese journal of clinical medicine 20080101 |
| Higher efficacy of urinary bone resorption marker measurements in assessing response to treatment for osteoporosis in postmenopausal women. | The Tohoku journal of experimental medicine 20080101 |
| [Guide for the prevention and treatment of glucocorticoid-induced osteoporosis of the Spanish Society of Internal Medicine]. | Revista clinica espanola 20080101 |
| Cancer treatment-related bone loss: a review and synthesis of the literature. | Current oncology (Toronto, Ont.) 20080101 |
| [Clinical significance of risedronate for patients with prostate cancer receiving androgen deprivation therapy]. | Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20080101 |
| Effects of bisphosphonates on fracture incidence and bone metabolism in rheumatoid arthritis patients in general practice taking long-term corticosteroid therapy: a retrospective study. | Clinical drug investigation 20080101 |
| Inhibition of RuBisCO cloned from Thermosynechococcus vulcanus and expressed in Escherichia coli with compounds predicted by Molecular Operation Environment (MOE). | Journal of bioscience and bioengineering 20080101 |
| Efficacy of risedronate in Japanese male patients with primary osteoporosis. | Internal medicine (Tokyo, Japan) 20080101 |
| Additive effects of glucosamine or risedronate for the treatment of osteoarthritis of the knee combined with home exercise: a prospective randomized 18-month trial. | Journal of bone and mineral metabolism 20080101 |
| Cost effectiveness of the German screen-and-treat strategy for postmenopausal osteoporosis. | PharmacoEconomics 20080101 |
| Protocol for stage 2 of the GaP study (genetic testing acceptability for Paget's disease of bone): a questionnaire study to investigate whether relatives of people with Paget's disease would accept genetic testing and preventive treatment if they were available. | BMC health services research 20080101 |
| Effect of risedronate on bone mass, remodelling and biomechanical strength in orchidectomized rats. | Hormone research 20080101 |
| Urinary osteocalcin and other markers of bone metabolism: the effect of risedronate therapy. | Scandinavian journal of clinical and laboratory investigation 20080101 |
| [Non-hormonal treatments of postmenopausal osteoporosis]. | Gynecologie, obstetrique & fertilite 20080101 |
| Effectiveness of risedronate in osteoporotic postmenopausal women with inflammatory bowel disease: a prospective, parallel, open-label, two-year extension study. | Menopause (New York, N.Y.) 20080101 |
| SPECT/CT-plethysmography--non-invasive quantitation of bone and soft tissue blood flow. | Journal of orthopaedic surgery and research 20080101 |
| Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines. | Anticancer research 20080101 |
| Therapy with zoledronic acid, 5 mg, for a patient with Paget disease of bone. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20080101 |
| Self-reported compliance with osteoporosis medication-qualitative aspects and correlates. | Maturitas 20080101 |
| TZDs and Bone: A Review of the Recent Clinical Evidence. | PPAR research 20080101 |
| Analgesic and chondroprotective effects of risedronate in osteoarthritis assessed by electroalgometry and measurement of collagen type II fragments in urine. | The Journal of international medical research 20080101 |
| Predicting in vivo efficacy of potential restenosis therapies by cell culture studies: species-dependent susceptibility of vascular smooth muscle cells. | The open cardiovascular medicine journal 20080101 |
| Tibolone inhibits bone resorption without secondary positive effects on cartilage degradation. | BMC musculoskeletal disorders 20080101 |
| [Differences among bisfosfonates--specificity of risedronate (Actonel)]. | Reumatizam 20080101 |
| Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system. | BMC musculoskeletal disorders 20080101 |
| Characteristics of patients initiating raloxifene compared to those initiating bisphosphonates. | BMC women's health 20080101 |
| Limited Wegener's granulomatosis presenting as lung nodules in a patient with rheumatoid arthritis: a case report. | Cases journal 20080101 |
| Medical treatment of otosclerosis: rationale for use of bisphosphonates. | The international tinnitus journal 20080101 |
| Cost effectiveness and cost utility of risedronate for osteoporosis treatment and fracture prevention in women: a Swiss perspective. | Journal of medical economics 20080101 |
| Our censored journals. | Mens sana monographs 20080101 |
| New dosing options in osteoporosis treatment: clinical evidence on Risedronate 75mg monthly treatment. | Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases 20080101 |
| Hip fractures in users of first- vs. second-generation bisphosphonates. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20071201 |
| [Osteoporosis and bisphosphonates]. | Zeitschrift fur Rheumatologie 20071201 |
| Monthly dosing with risedronate 50 mg on three consecutive days a month compared with daily dosing with risedronate 5 mg: a 6-month pilot study. | Current medical research and opinion 20071201 |
| Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20071201 |
| Preventive effect of risedronate on bone loss in men receiving androgen-deprivation therapy for prostate cancer. | International journal of urology : official journal of the Japanese Urological Association 20071201 |
| Evidence based medicine and effective interventions of pharmacological therapy for the prevention of osteoporotic fractures. | Minerva endocrinologica 20071201 |
| Teriparatide in the management of osteoporosis. | Clinical interventions in aging 20071201 |
| Osteoporosis in the aging male: treatment options. | Clinical interventions in aging 20071201 |
| Synthesis and biological evaluation of alpha-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate. | Journal of medicinal chemistry 20071129 |
| [HIP study--how to prevent hip fractures?]. | Nihon rinsho. Japanese journal of clinical medicine 20071128 |
| [FACT study]. | Nihon rinsho. Japanese journal of clinical medicine 20071128 |
| [Bisphosphonates for osteoporosis]. | Nihon rinsho. Japanese journal of clinical medicine 20071128 |
| [Evidence of risedronate for treatment of osteoporosis]. | Nihon rinsho. Japanese journal of clinical medicine 20071128 |
| [Efficacy and tolerability of once-weekly administration of 35 mg alendronate and 17.5 mg risedronate]. | Nihon rinsho. Japanese journal of clinical medicine 20071128 |
| Management of cancer treatment-induced bone loss in early breast and prostate cancer -- a consensus paper of the Belgian Bone Club. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20071101 |
| Consequences of poor compliance with bisphosphonates. | Bone 20071101 |
| Risedronate did not block the maximal anabolic effect of PTH in aged rats. | Bone 20071101 |
| The degree of bone mineralization is maintained with single intravenous bisphosphonates in aged estrogen-deficient rats and is a strong predictor of bone strength. | Bone 20071101 |
| Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women. | Current medical research and opinion 20071101 |
| Isoprenoid-independent pathway is involved in apoptosis induced by risedronate, a bisphosphonate, in which Bim plays a critical role in breast cancer cell line MCF-7. | Oncology reports 20071101 |
| Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate: review of statistical analysis. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20071101 |
| Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis--usefulness of alendronate and risedronate. | Expert opinion on pharmacotherapy 20071101 |
| Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates. | Journal of dental research 20071101 |
| The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of glucocorticoids. | Arthritis and rheumatism 20071101 |
| Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. | Annals of the New York Academy of Sciences 20071101 |
| [Mandible osteonechrosis associated to bisfosfonates]. | Ginecologia y obstetricia de Mexico 20071101 |
| Evaluation of 41calcium as a new approach to assess changes in bone metabolism: effect of a bisphosphonate intervention in postmenopausal women with low bone mass. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20071001 |
| Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates: a bone biopsy study. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20071001 |
| Aromatase inhibitor-induced bone mineral loss and its prevention by bisphosphonate administration in postmenopausal breast cancer patients. | The journal of obstetrics and gynaecology research 20071001 |
| Osteoporosis: non-hormonal treatment. | Climacteric : the journal of the International Menopause Society 20071001 |
| Atypical Paget's disease with quantitative assessment of tracer kinetics. | Clinical nuclear medicine 20071001 |
| [Osteoporosis in the patients with rheumatoid arthritis (3) : the efficacy and the selection of the osteoporosis therapeutic drug]. | Clinical calcium 20071001 |
| Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats. | Journal of endocrinological investigation 20071001 |
| Use of zoledronic acid in the treatment of Paget's disease. | Therapeutics and clinical risk management 20071001 |
| Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates. | Bone 20070901 |
| Osteoporosis medication profile preference: results from the PREFER-US study. | Health expectations : an international journal of public participation in health care and health policy 20070901 |
| Persistence across weekly and monthly bisphosphonates: analysis of US retail pharmacy prescription refills. | Current medical research and opinion 20070901 |
| Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices. | Journal of periodontology 20070901 |
| Comparative studies on effect of risedronate and alfacalcidol against glucocorticoid-induced osteoporosis in rheumatoid arthritic patients. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20070901 |
| Update on osteoporosis management in long-term care: focus on bisphosphonates. | Journal of the American Medical Directors Association 20070901 |
| Use of osteoporosis medications in older nursing facility residents. | Journal of the American Medical Directors Association 20070901 |
| Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial. | Clinical therapeutics 20070901 |
| Review of the safety and efficacy of risedronate for the treatment of male osteoporosis. | Clinical interventions in aging 20070901 |
| Update on bazedoxifene: a novel selective estrogen receptor modulator. | Clinical interventions in aging 20070901 |
| Osteoporosis screening and risk management. | Clinical interventions in aging 20070901 |
| Fracture prevention in postmenopausal women. | BMJ clinical evidence 20070901 |
| Yearly zoledronic acid in postmenopausal osteoporosis. | The New England journal of medicine 20070816 |
| Weekly risedronate in kidney transplant patients with osteopenia. | Transplant international : official journal of the European Society for Organ Transplantation 20070801 |
| Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume. | Calcified tissue international 20070801 |
| A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. | Clinical therapeutics 20070801 |
| [Glucocorticoid-induced osteoporosis]. | Polskie Archiwum Medycyny Wewnetrznej 20070801 |
| Oral bisphosphonate associated osteonecrosis of the jaws: three case reports. | British dental journal 20070728 |
| WITHDRAWN: Risedronate for the prevention and treatment of postmenopausal osteoporosis. | The Cochrane database of systematic reviews 20070718 |
| Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen alone or in combination) trial. | British journal of cancer 20070716 |
| Assessment of non-vertebral fracture risk in postmenopausal women. | Annals of the rheumatic diseases 20070701 |
| Is cortical bone hip? What determines cortical bone properties? | Bone 20070701 |
| Is risedronate or alendronate more effective at preventing nonvertebral fractures in women with osteoporosis? | Nature clinical practice. Rheumatology 20070701 |
| Risedronate reduces postoperative bone resorption after cementless total hip arthroplasty. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20070701 |
| [Osteoporosis treatment: choices and options]. | Polskie Archiwum Medycyny Wewnetrznej 20070701 |
| Multiple hereditary osteochondromatosis: a case report. | European journal of dentistry 20070701 |
| Bisphosphonates: are they standard of care for the treatment of breast cancer? | British journal of cancer 20070618 |
| Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases. | Proceedings of the National Academy of Sciences of the United States of America 20070612 |
| Effect of risedronate on high-dose corticosteroid-induced bone loss in patients with glomerular disease. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070601 |
| Risedronate, an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD). | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070601 |
| Osteonecrosis of the jaws associated with use of risedronate: report of 2 new cases. | Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20070601 |
| Update on the use of bisphosphonates in the management of postmenopausal osteoporosis by obstetricians-gynecologists. | Obstetrical & gynecological survey 20070601 |
| Prescriptions for vitamin D among patients taking antiresorptive agents in Canada. | Current medical research and opinion 20070601 |
| Pharmacological treatment of osteoporosis for people over 70. | Aging clinical and experimental research 20070601 |
| Clinical evaluation of novel bisphosphonate dosing regimens in osteoporosis: the role of comparative studies and implications for future studies. | Clinical therapeutics 20070601 |
| The futility of current approaches to chondroprotection. | Arthritis and rheumatism 20070501 |
| Bisphosphonates. A cornerstone of osteoporosis treatment. | Mayo Clinic women's healthsource 20070501 |
| Advances in the management of corticosteroid-induced osteoporosis with bisphosphonates. | Clinical rheumatology 20070401 |
| Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading. | Bone 20070401 |
| Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis. | The Journal of clinical endocrinology and metabolism 20070401 |
| Can treatment with risedronate benefit patients with knee osteoarthritis? | Nature clinical practice. Rheumatology 20070401 |
| [Secondary osteoporosis. Evidence of treatment efficacy in patients with glucocorticoid-induced osteoporosis]. | Clinical calcium 20070401 |
| Additive effect of vitamin K2 and risedronate on long bone mass in hypophysectomized young rats. | Experimental animals 20070401 |
| [Osteoporosis compounds in general practice. That is REAL: in routine practice the better choice]. | MMW Fortschritte der Medizin 20070329 |
| Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease. | Neurology 20070320 |
| Effect of administration site in the gastrointestinal tract on bioavailability of poorly absorbed drugs taken after a meal. | Journal of controlled release : official journal of the Controlled Release Society 20070312 |
| Risedronate for the prevention of hip fractures: concern about validity of trials. | Archives of internal medicine 20070312 |
| Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro. | Biochemical pharmacology 20070301 |
| Discontinuation of antiresorptive therapies: a comparison between 1998-2001 and 2002-2004 among osteoporotic women. | The Journal of clinical endocrinology and metabolism 20070301 |
| Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis. | Health technology assessment (Winchester, England) 20070301 |
| Bisphosphonates: mode of action and pharmacology. | Pediatrics 20070301 |
| Bone quality: an empty term. | PLoS medicine 20070301 |
| Risedronate-induced Hepatitis. | The American journal of medicine 20070301 |
| Gaps in treatment among users of osteoporosis medications: the dynamics of noncompliance. | The American journal of medicine 20070301 |
| Osteochemonecrosis of jaws and bisphosphonates. | Irish medical journal 20070301 |
| The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis. | Clinical interventions in aging 20070301 |
| Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women. | Clinical interventions in aging 20070301 |
| Development and validation of a reversed-phase ion-pair high-performance liquid chromatographic method for the determination of risedronate in pharmaceutical preparations. | Analytica chimica acta 20070212 |
| Differential effects of bisphosphonates on breast cancer cell lines. | Cancer letters 20070208 |
| Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures. | Clinical rheumatology 20070201 |
| A 2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients. | Rheumatology (Oxford, England) 20070201 |
| Effects of calcitonin, risedronate, and raloxifene on erythrocyte antioxidant enzyme activity, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. | Archives of medical research 20070201 |
| Weekly alendronate versus risedronate for postmenopausal osteoporosis--is there a difference? | Nature clinical practice. Endocrinology & metabolism 20070201 |
| Osteoporosis: strategies for prevention and management. | Best practice & research. Clinical rheumatology 20070201 |
| Bisphosphonate use in the treatment of Paget's disease of the bone: analysis of claims in a large database. | Managed care interface 20070201 |
| Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20070101 |
| Prevention of bone loss in survivors of breast cancer: A randomized, double-blind, placebo-controlled clinical trial. | The Journal of clinical endocrinology and metabolism 20070101 |
| Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20070101 |
| Effects of osteoporosis medications on bone quality. | Joint, bone, spine : revue du rhumatisme 20070101 |
| The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis. | BMC musculoskeletal disorders 20070101 |
| The diagnosis and treatment of male osteoporosis: Defining, assessing, and preventing skeletal fragility in men. | European journal of internal medicine 20070101 |
| How long should patients take medications for postmenopausal osteoporosis? | Joint, bone, spine : revue du rhumatisme 20070101 |
| Reconciling competing priorities in commissioning: the future of bone densitometry service for North Wales. | Cost effectiveness and resource allocation : C/E 20070101 |
| The relationship between regional bone turnover measured using 18F-fluoride positron emission tomography and changes in BMD is equivalent to that seen for biochemical markers of bone turnover. | Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20070101 |
| The teriparatide in the treatment of severe senile osteoporosis. | Archives of gerontology and geriatrics 20070101 |
| Comparison of raloxifene and bisphosphonates based on adherence and treatment satisfaction in postmenopausal Asian women. | Journal of bone and mineral metabolism 20070101 |
| Changes in bone resorption markers among Japanese patients with postmenopausal osteoporosis treated with alendronate and risedronate. | Journal of bone and mineral metabolism 20070101 |
| The Interleukin-6 inflammation pathway from cholesterol to aging--role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases. | Immunity & ageing : I & A 20070101 |
| [Bisphosphonates-associated osteonecrosis of the jaw: review on reported cases]. | Therapie 20070101 |
| Zoledronic acid: a review of its use in the treatment of Paget's disease of bone. | Drugs 20070101 |
| Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia. | BMC women's health 20070101 |
| [The effect of risedronate treatment on bone turnover markers in patients with hip fracture]. | Acta orthopaedica et traumatologica turcica 20070101 |
| The effect of alendronate, risedronate, and raloxifene on renal functions, based on the Cockcroft and Gault method, in postmenopausal women. | Renal failure 20070101 |
| Intermittent bisphosphonate therapy in postmenopausal osteoporosis: progress to date. | Drugs & aging 20070101 |
| Treatment with tiludronate has a similar effect to risedronate on Paget's disease activity assessed by bone markers and bone scintigraphy. | Clinical and experimental rheumatology 20070101 |
| Bisphosphonates and osteonecrosis of the jaw: a retrospective study. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20070101 |
| A computational assessment of the independent contribution of changes in canine trabecular bone volume fraction and microarchitecture to increased bone strength with suppression of bone turnover. | Journal of biomechanics 20070101 |
| Common musculoskeletal adverse effects of oral treatment with once weekly alendronate and risedronate in patients with osteoporosis and ways for their prevention. | Journal of musculoskeletal & neuronal interactions 20070101 |
| Role of RANKL inhibition in osteoporosis. | Arthritis research & therapy 20070101 |
| Clinical development of anti-RANKL therapy. | Arthritis research & therapy 20070101 |
| The role of PET/CT in Cogan's syndrome. | Clinical rheumatology 20070101 |
| Hypocalcemia after alendronate therapy in a patient with celiac disease. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20070101 |
| Risk factors associated with the loss of cartilage volume on weight-bearing areas in knee osteoarthritis patients assessed by quantitative magnetic resonance imaging: a longitudinal study. | Arthritis research & therapy 20070101 |
| A case of pachydermoperiostosis treated by oral administration of a bisphosphonate and arthroscopic synovectomy. | Modern rheumatology 20070101 |
| Factors affecting long-term compliance of osteoporotic patients with bisphosphonate treatment and QOL assessment in actual practice: alendronate and risedronate. | Journal of bone and mineral metabolism 20070101 |
| Risedronate has no adverse effects on mouse haematopoiesis. | Folia biologica 20070101 |
| Safety considerations with bisphosphonates for the treatment of osteoporosis. | Drug safety 20070101 |
| Oral bisphosphonate adverse effects in 849 patients with metabolic bone diseases. | Hormones (Athens, Greece) 20070101 |
| [Advances in the treatment of postmenopausal osteoporosis]. | Revue medicale de Liege 20070101 |
| The association between compliance and persistence with bisphosphonate therapy and fracture risk: a review. | BMC musculoskeletal disorders 20070101 |
| Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-beta/bone morphogenic protein signalling. | Arthritis research & therapy 20070101 |
| High-dose bisphosphonate therapy in an urgent case of spontaneous multiple vertebral fractures in a 55 year old woman. | Wiener medizinische Wochenschrift (1946) 20070101 |
| The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature. | PharmacoEconomics 20070101 |
| The quest for the Holy Grail: a disease-modifying osteoarthritis drug. | Arthritis research & therapy 20070101 |
| Risedronate induced transient ocular myasthenia. | Journal of postgraduate medicine 20070101 |
| Effect of bisphosphonates on nitric oxide production by inflammatory activated chondrocytes. | Clinical and experimental rheumatology 20070101 |
| [Risedronate (Actonel)--from randomized clinical trials to real life]. | Reumatizam 20070101 |
| Treatment of bisphosphonates-associated osteonecrosis. | Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases 20070101 |
| Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin. | Journal of medicinal chemistry 20061214 |
| Access to bone mineral density testing in patients at risk for osteoporosis. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20061201 |
| Dehydration of risedronate hemi-pentahydrate: analytical and physical characterization. | Journal of pharmaceutical sciences 20061201 |
| Using computers to identify non-compliant people at increased risk of osteoporotic fractures in general practice: a cross-sectional study. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20061201 |
| Transmigration: a new property of mature multinucleated osteoclasts. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20061201 |
| [Prevention of osteoporotic fracture by pharmaceutical interventions]. | Clinical calcium 20061201 |
| Drug insight: Existing and emerging therapies for osteoporosis. | Nature clinical practice. Endocrinology & metabolism 20061201 |
| Medical management of Paget's disease of bone: indications for treatment and review of current therapies. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20061201 |
| European women's preference for osteoporosis treatment: influence of clinical effectiveness and dosing frequency. | Current medical research and opinion 20061201 |
| Patient preference and adherence: comparative US studies between two bisphosphonates, weekly risedronate and monthly ibandronate. | Current medical research and opinion 20061201 |
| Bisphosphonates. | Annals of the New York Academy of Sciences 20061201 |
| Effect of risedronate on the cortical and cancellous bone mass and mechanical properties in ovariectomized rats: a comparison with the effects of alfacalcidol. | Journal of nutritional science and vitaminology 20061201 |
| Strontium ranelate: a novel treatment for postmenopausal osteoporosis: a review of safety and efficacy. | Clinical interventions in aging 20061201 |
| Comparative effects of antiresorptive agents on bone mineral density and bone turnover in postmenopausal women. | Clinical interventions in aging 20061201 |
| Patient preference in the management of postmenopausal osteoporosis with bisphosphonates. | Clinical interventions in aging 20061201 |
| [Men also need bone protection]. | MMW Fortschritte der Medizin 20061116 |
| [Correlation between studies and general practice]. | MMW Fortschritte der Medizin 20061116 |
| Characterization of the farnesyl pyrophosphate synthase of Trypanosoma cruzi by homology modeling and molecular dynamics. | Journal of molecular graphics & modelling 20061101 |
| RETRACTED: Etidronate for fracture prevention in amyotrophic lateral sclerosis: a randomized controlled trial. | Bone 20061101 |
| Serum NTX is a practical marker for assessing antiresorptive therapy for glucocorticoid treated patients with chronic kidney disease. | Bone 20061101 |
| Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia. | Bone 20061101 |
| Raloxifene enhances vertebral mechanical properties independent of bone density. | Bone 20061101 |
| Hip and non-spine fracture risk reductions differ among antiresorptive agents: Evidence from randomised controlled trials. | International journal of clinical practice 20061101 |
| Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. | Arthritis and rheumatism 20061101 |
| [Randomized controlled trials for the prevention and treatment of glucocorticoid-induced osteoporosis]. | Clinical calcium 20061101 |
| Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users. | Pharmacoepidemiology and drug safety 20061001 |
| Is the increase in osteoporosis prevention a result of the audit? | Clinical neurology and neurosurgery 20061001 |
| Bisphosphonates activate nucleotide receptors signaling and induce the expression of Hsp90 in osteoblast-like cell lines. | Bone 20061001 |
| Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate. | Bone 20061001 |
| Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone. | Bone 20061001 |
| Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20061001 |
| Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20061001 |
| Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men. | Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20061001 |
| Antiremodeling agents influence osteoblast activity differently in modeling and remodeling sites of canine rib. | Calcified tissue international 20061001 |
| Effect of pre- and post-surgery treatment with risedronate on trabecular bone loss in ovariectomized rats. | Experimental animals 20061001 |
| The effect of dosing frequency on compliance and persistence with bisphosphonate therapy in postmenopausal women: a comparison of studies in the United States, the United Kingdom, and France. | Clinical therapeutics 20061001 |
| Beneficial effect of pretreatment and treatment continuation with risedronate and vitamin K2 on cancellous bone loss after ovariectomy in rats: a bone histomorphometry study. | Journal of nutritional science and vitaminology 20061001 |
| [A young woman with headaches and skull anomalies: a long road to the diagnosis 'Paget's disease']. | Nederlands tijdschrift voor geneeskunde 20060930 |
| Antioxidant effect of bisphosphonates and simvastatin on chondrocyte lipid peroxidation. | Biochemical and biophysical research communications 20060922 |
| Activity of nitrogen-containing and non-nitrogen-containing bisphosphonates on tumor cell lines. | Journal of medicinal chemistry 20060921 |
| Selective inhibition of Rab prenylation by a phosphonocarboxylate analogue of risedronate induces apoptosis, but not S-phase arrest, in human myeloma cells. | International journal of cancer 20060915 |
| Effects of a prostaglandin EP4 agonist, ONO-4819, and risedronate on trabecular microstructure and bone strength in mature ovariectomized rats. | Bone 20060901 |
| Sequential treatment of ovariectomized mice with bFGF and risedronate restored trabecular bone microarchitecture and mineralization. | Bone 20060901 |
| [Role of OPG in regulation of bone remodeling]. | Clinical calcium 20060901 |
| [Therapeutic effects of risedronate on Paget's disease of bone]. | Clinical calcium 20060901 |
| Persistent bisphosphonate use and the risk of osteoporotic fractures in clinical practice: a database analysis study. | Current medical research and opinion 20060901 |
| [Effects of bisphosphonate for quality and strength of bone]. | Nihon rinsho. Japanese journal of clinical medicine 20060901 |
| [Paget's disease of bone]. | Nihon rinsho. Japanese journal of clinical medicine 20060901 |
| Alendronate sodium in the management of osteoporosis. | Therapeutics and clinical risk management 20060901 |
| Management of age-related osteoporosis and prevention of associated fractures. | Therapeutics and clinical risk management 20060901 |
| New options of pharmacological treatment of osteoporosis. | Ortopedia, traumatologia, rehabilitacja 20060831 |
| Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: sequential triple biopsy studies with micro-computed tomography. | Bone 20060801 |
| Chemical makeup of microdamaged bone differs from undamaged bone. | Bone 20060801 |
| Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study. | International journal of clinical practice 20060801 |
| Developments in the pharmacotherapeutic management of osteoporosis. | Expert opinion on pharmacotherapy 20060801 |
| Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy? | Annals of oncology : official journal of the European Society for Medical Oncology 20060801 |
| Madarosis from mitochondriopathy. | Acta ophthalmologica Scandinavica 20060801 |
| The effects of antifracture therapies on the components of bone strength: assessment of fracture risk today and in the future. | Seminars in arthritis and rheumatism 20060801 |
| Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. | Mayo Clinic proceedings 20060801 |
| Aromatase inhibitors and bone loss. | Oncology (Williston Park, N.Y.) 20060801 |
| Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years. | The Journal of clinical endocrinology and metabolism 20060701 |
| Drug combination strategies for osteoporosis. | Joint, bone, spine : revue du rhumatisme 20060701 |
| Anti-inflammatory and anti-nociceptive activity of risedronate in experimental pain models in rats and mice. | Clinical and experimental pharmacology & physiology 20060701 |
| Effects of 3- and 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20060701 |
| Cost-effectiveness of alternative treatments for women with osteoporosis in Canada. | Current medical research and opinion 20060701 |
| Farnesyl diphosphate synthase is a cytosolic enzyme in Leishmania major promastigotes and its overexpression confers resistance to risedronate. | Eukaryotic cell 20060701 |
| Therapeutic effect of risedronate on cancellous and cortical bone in ovariectomized osteopenic rats: a comparison with the effects of alfacalcidol. | Experimental animals 20060701 |
| Preventive effects of risedronate and calcitriol on cancellous osteopenia in rats treated with high-dose glucocorticoid. | Experimental animals 20060701 |
| Prescription drug therapies for prevention and treatment of postmenopausal osteoporosis. | Journal of managed care pharmacy : JMCP 20060701 |
| An approach to compare the quality of cancellous bone from the femoral necks of healthy and osteoporotic patients through compression testing and microcomputed tomography imaging. | McGill journal of medicine : MJM : an international forum for the advancement of medical sciences by students 20060701 |
| [Substance properties of zoledronate make it possible: bisphosphonate therapy only once yearly]. | MMW Fortschritte der Medizin 20060622 |
| Medial tibial stress syndrome due to methotrexate osteopathy. | Annals of the rheumatic diseases 20060601 |
| Long-term experience with alendronate in the treatment of osteoporosis. | Expert opinion on pharmacotherapy 20060601 |
| How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy. | The Annals of pharmacotherapy 20060601 |
| Adherence and persistence associated with the pharmacologic treatment of osteoporosis in a managed care setting. | Southern medical journal 20060601 |
| Effects of risedronate on lumbar bone mineral density, bone resorption, and incidence of vertebral fracture in elderly male patients with leprosy. | Leprosy review 20060601 |
| Fracture prevention in postmenopausal women. | Clinical evidence 20060601 |
| Postmenopausal osteoporosis. What have we learned since the introduction of bisphosphonates? | Reviews in endocrine & metabolic disorders 20060601 |
| The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs. | Proceedings of the National Academy of Sciences of the United States of America 20060516 |
| [Only bone densitometry answers this question. How stable are your patients' bones?]. | MMW Fortschritte der Medizin 20060504 |
| Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. | Bone 20060501 |
| Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy. | Bone 20060501 |
| Bisphosphonates inhibit the growth of mesothelioma cells in vitro and in vivo. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060501 |
| Between-meal risedronate does not alter bone turnover in nursing home residents. | Journal of the American Geriatrics Society 20060501 |
| Osteoporosis in older people: a tale of two studies (and three treatments). | Journal of the American Geriatrics Society 20060501 |
| Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis. | Current medical research and opinion 20060501 |
| Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac, Cdc42, and Rho GTPases. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20060501 |
| Is a single infusion of zoledronic acid superior to risedronate for the treatment of Paget's disease? | Nature clinical practice. Endocrinology & metabolism 20060501 |
| Effects of vitamin K2 on the development of osteopenia in rats as the models of osteoporosis. | Yonsei medical journal 20060430 |
| Oral ibandronate in the management of postmenopausal osteoporosis: review of upper gastrointestinal safety. | Maturitas 20060420 |
| Alendronate in bone cement: fatigue life degraded by liquid, not by powder. | Clinical orthopaedics and related research 20060401 |
| Preventing osteoporosis-related fractures: an overview. | The American journal of medicine 20060401 |
| Female sexual dysfunction: a case study of disease mongering and activist resistance. | PLoS medicine 20060401 |
| Strontium ranelate for osteoporosis? | Drug and therapeutics bulletin 20060401 |
| Efficacy and acceptability of risedronate 5 mg daily compared with 35 mg once weekly for the treatment of postmenopausal osteoporosis. | Climacteric : the journal of the International Menopause Society 20060401 |
| Bisphosphonates: from bench to bedside. | Annals of the New York Academy of Sciences 20060401 |
| Drug insight: Bisphosphonates for postmenopausal osteoporosis. | Nature clinical practice. Endocrinology & metabolism 20060401 |
| Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease? | Nature clinical practice. Rheumatology 20060401 |
| Esophageal transit of the weekly film-coated risedronate (Actonel) placebo tablet in subjects with Kyphosis. | International journal of pharmaceutics 20060327 |
| Enthalpy versus entropy-driven binding of bisphosphonates to farnesyl diphosphate synthase. | Journal of the American Chemical Society 20060322 |
| [Pharmacotherapy of osteoporosis: evidence-based clinical practice]. | Medizinische Klinik (Munich, Germany : 1983) 20060322 |
| Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study. | Rheumatology international 20060301 |
| Ammonium 1-hydroxy-2-(2-pyridinio)ethane-1,1-diyldiphosphonate dihydrate and potassium 1-hydroxy-2-(2-pyridinio)ethane-1,1-diyldiphosphonate dihydrate. | Acta crystallographica. Section C, Crystal structure communications 20060301 |
| Osteoporosis drug may protect joints. | Health news (Waltham, Mass.) 20060301 |
| Osteoporosis management in a Medicaid population after the Women's Health Initiative study. | Journal of women's health (2002) 20060301 |
| Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis. | Therapeutics and clinical risk management 20060301 |
| Differences between the bisphosphonates for the prevention and treatment of osteoporosis. | Therapeutics and clinical risk management 20060301 |
| Long-term use of bisphosphonates in osteoporosis. | Women's health (London, England) 20060301 |
| Potential adverse effects. | British dental journal 20060211 |
| Hospitalization-related bone loss and the protective effect of risedronate. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060201 |
| Pharmacological therapy of Paget's and other metabolic bone diseases. | Bone 20060201 |
| Patients with hip fracture: what can be improved? | Bone 20060201 |
| Strategies for the prevention and treatment of osteoporosis during early postmenopause. | American journal of obstetrics and gynecology 20060201 |
| [Application of anti-resorptive drugs for the treatment of osteoporosis]. | Nihon rinsho. Japanese journal of clinical medicine 20060201 |
| Long-term outcome of weekly bisphosphonates. | Clinical orthopaedics and related research 20060201 |
| Anti-hip fracture efficacy of biophosphonates: a Bayesian analysis of clinical trials. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20060201 |
| Comparative effects of risedronate and calcitriol on cancellous bone in rats with glucocorticoid-induced osteopenia. | Journal of nutritional science and vitaminology 20060201 |
| Update of current therapeutic options for the treatment of postmenopausal osteoporosis. | Clinical therapeutics 20060201 |
| Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis. | Clinical therapeutics 20060201 |
| [Osteoporosis treatment]. | Revue medicale suisse 20060104 |
| Comparison of the effects of alendronate and risedronate on bone mineral density and bone turnover markers in postmenopausal osteoporosis. | Rheumatology international 20060101 |
| Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060101 |
| Effects of various antireabsorptive treatments on bone mineral density in hypogonadal young women after allogeneic stem cell transplantation. | Bone marrow transplantation 20060101 |
| Structure and mechanism of the farnesyl diphosphate synthase from Trypanosoma cruzi: implications for drug design. | Proteins 20060101 |
| Fracture prevention in postmenopausal osteoporosis: a review of treatment options. | Obstetrical & gynecological survey 20060101 |
| The treatment of severe postmenopausal osteoporosis : a review of current and emerging therapeutic options. | Treatments in endocrinology 20060101 |
| Osteoporosis in postmenopausal women. Therapy options across a wide range of risk for fracture. | Geriatrics 20060101 |
| A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease. | The American journal of gastroenterology 20060101 |
| Glucocorticoid-induced bone loss in dermatologic patients: an update. | Archives of dermatology 20060101 |
| Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060101 |
| Ophthalmological events in patients receiving risedronate: summary of information gained through follow-up in a prescription-event monitoring study in England. | Drug safety 20060101 |
| Are osteoporotic fractures being adequately investigated? A questionnaire of GP & orthopaedic surgeons. | BMC family practice 20060101 |
| Clinical significance of risedronate for osteoporosis in the initial treatment of male patients with Graves' disease. | Journal of bone and mineral metabolism 20060101 |
| [Your patients face the treatment of osteoporosis: How to improve the efficacy of management in clinical practice?]. | La Revue du praticien 20060101 |
| Bisphosphonates are effective prophylactic of early bone loss after renal transplantation. | Transplantation proceedings 20060101 |
| Determinants of adherence to osteoporosis treatment in clinical practice. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060101 |
| Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells. | BMC cancer 20060101 |
| Drug injury in the upper gastrointestinal tract: effects of alendronate. | Gastrointestinal endoscopy clinics of North America 20060101 |
| Challenges of recruitment of breast cancer survivors to a randomized clinical trial for osteoporosis prevention. | Cancer nursing 20060101 |
| Most recent developments in strategies to reduce the progression of structural changes in osteoarthritis: today and tomorrow. | Arthritis research & therapy 20060101 |
| The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060101 |
| Effect of risedronate on bone metabolism after total hip arthroplasty: a prospective randomised study. | Acta orthopaedica Belgica 20060101 |
| [Glucocorticoid-induced osteoporosis and rheumatic diseases. Pathogenesis, prevention and treatment]. | Reumatismo 20060101 |
| The effects of organic nitrates on osteoporosis: a randomized controlled trial [ISRCTN94484747]. | Trials 20060101 |
| Osteoporosis in patients with inflammatory bowel disease: risk factors, prevention, and treatment. | Reviews in gastroenterological disorders 20060101 |
| Channeling and adherence with alendronate and risedronate among chronic glucocorticoid users. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060101 |
| Long-term safety of bisphosphonate therapy for osteoporosis: a review of the evidence. | Drugs & aging 20060101 |
| Protocol for stage 1 of the GaP study (Genetic testing acceptability for Paget's disease of bone): an interview study about genetic testing and preventive treatment: would relatives of people with Paget's disease want testing and treatment if they were available? | BMC health services research 20060101 |
| In vitro effects of aminobisphosphonates on Vgamma9Vdelta2 T cell activation and differentiation. | International journal of immunopathology and pharmacology 20060101 |
| Psychometric evaluation of the Osteoporosis Patient Treatment Satisfaction Questionnaire (OPSAT-Q), a novel measure to assess satisfaction with bisphosphonate treatment in postmenopausal women. | Health and quality of life outcomes 20060101 |
| Importance of calcium co-medication in bisphosphonate therapy of osteoporosis: an approach to improving correct intake and drug adherence. | Drugs & aging 20060101 |
| Guidelines for diagnosis and management of Paget's disease of bone in Japan. | Journal of bone and mineral metabolism 20060101 |
| Efficacy and tolerability of once-weekly administration of 17.5 mg risedronate in Japanese patients with involutional osteoporosis: a comparison with 2.5-mg once-daily dosage regimen. | Journal of bone and mineral metabolism 20060101 |
| Antiepileptic drugs and bone metabolism. | Nutrition & metabolism 20060101 |
| Medication persistence with weekly versus daily doses of orally administered bisphosphonates. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20060101 |
| Neuroaxial anesthesia in a patient with progressive systemic sclerosis : case presentation and review of the literature on systemic sclerosis. | BMC anesthesiology 20060101 |
| Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role. | Arthritis research & therapy 20060101 |
| A general approach for the quantitative analysis of bisphosphonates in human serum and urine by high-performance liquid chromatography/tandem mass spectrometry. | Rapid communications in mass spectrometry : RCM 20060101 |
| Skeletal effects of short-term exposure to dexamethasone and response to risedronate treatment studied in vivo in rabbits by magnetic resonance micro-imaging and spectroscopy. | Journal of bone and mineral metabolism 20060101 |
| [Biphosphonate-associated osteonecrosis of the maxilla. Case report and review of the literature]. | Schweizer Monatsschrift fur Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia 20060101 |
| Comparative therapeutic use of Risedronate and Calcarea phosphorica--allopathy versus homeopathy--in bone repair in castrated rats. | Brazilian oral research 20060101 |
| Tolerability of different dosing regimens of bisphosphonates for the treatment of osteoporosis and malignant bone disease. | Drug safety 20060101 |
| Alendronic acid produces greater effects than risedronic acid on bone density and turnover in postmenopausal women with osteoporosis : results of FACTS -international. | Clinical drug investigation 20060101 |
| Recognition of women at risk for fracture and intervention with fast-acting therapies. | International journal of fertility and women's medicine 20060101 |
| Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis. | Advances in therapy 20060101 |
| [Treatment of osteoporosis by risedronate-- speed, efficacy and safety]. | Reumatizam 20060101 |
| Osteoporosis in men and women. | Clinical cornerstone 20060101 |
| Pharmacologic and nonpharmacologic management of osteoporosis. | Clinical cornerstone 20060101 |
| Role of vitamin K2 in the treatment of postmenopausal osteoporosis. | Current drug safety 20060101 |
| Comparison of effect of treatment with etidronate and alendronate on lumbar bone mineral density in elderly women with osteoporosis. | Yonsei medical journal 20051231 |
| Paget's disease and bisphosphonates. | The New England journal of medicine 20051215 |
| Paget's disease and bisphosphonates. | The New England journal of medicine 20051215 |
| [Optimizing therapy in Paget disease]. | MMW Fortschritte der Medizin 20051215 |
| One drug tackles two diseases. | British dental journal 20051210 |
| Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells. | Biomaterials 20051201 |
| Osteoclast responses to lipopolysaccharide, parathyroid hormone and bisphosphonates in neonatal murine calvaria analyzed by laser scanning confocal microscopy. | The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 20051201 |
| Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20051201 |
| Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20051201 |
| Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20051201 |
| Prevention and treatment of glucocorticoid-induced osteoporosis in 2005. | Joint, bone, spine : revue du rhumatisme 20051201 |
| Symptomatic hypocalcemia due to oral risedronate therapy. | Indian journal of medical sciences 20051201 |
| Ibandronate: a new oral bisphosphonate for postmenopausal osteoporosis. | The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20051201 |
| Prescribing errors and other problems reported by community pharmacists. | Therapeutics and clinical risk management 20051201 |
| [Examination and treatment of orthopedic-surgery patients with osteoporosis-related fragility fractures]. | Ugeskrift for laeger 20051121 |
| Compliance with osteoporosis medications. | Archives of internal medicine 20051114 |
| Risedronate therapy for prevention of hip fracture after stroke in elderly women. | Neurology 20051108 |
| Risedronate-induced intravascular haemolysis complicated by acute tubular necrosis. | Clinical rheumatology 20051101 |
| A rational approach to evidence gaps in the management of osteoporosis. | The American journal of medicine 20051101 |
| [Practical approaches to the osteoporosis treatment--instructions for drug use that draws the effect of the medicine]. | Nihon rinsho. Japanese journal of clinical medicine 20051101 |
| [Antiresorptive treatment after proximal femur fracture]. | Atencion primaria 20051101 |
| Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20051001 |
| Madarosis from mitochondriopathy. | Acta ophthalmologica Scandinavica 20051001 |
| Upper gastrointestinal tract safety of daily oral risedronate in patients taking NSAIDs: a randomized, double-blind, placebo-controlled trial. | Mayo Clinic proceedings 20051001 |
| Review of treatment modalities for postmenopausal osteoporosis. | Southern medical journal 20051001 |
| Preparation and evaluation of floating risedronate sodium-Gelucire 43/01 formulations. | Drug development and industrial pharmacy 20051001 |
| Profound refractory hypocalcemia after thyroidectomy in a patient receiving chronic oral bisphosphonate therapy. | The American surgeon 20051001 |
| Monitoring of Risedronate by biochemical bone markers in clinical practice. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20051001 |
| Effects of risedronate on trabecular microstructure and biomechanical properties in ovariectomized rat tibia. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20050901 |
| Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20050901 |
| Phosphonocarboxylate inhibitors of Rab geranylgeranyl transferase disrupt the prenylation and membrane localization of Rab proteins in osteoclasts in vitro and in vivo. | Bone 20050901 |
| High-dose risedronate treatment partially preserves cancellous bone mass and microarchitecture during long-term disuse. | Bone 20050901 |
| Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. | The New England journal of medicine 20050901 |
| Bisphosphonates reduce bone mineral loss at ligament entheses after joint injury. | Osteoarthritis and cartilage 20050901 |
| Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. | Current medical research and opinion 20050901 |
| Bone remodeling at the iliac crest can predict the changes in remodeling dynamics, microdamage accumulation, and mechanical properties in the lumbar vertebrae of dogs. | Calcified tissue international 20050901 |
| [Risedronate: a possible treatment for extraosseous calcification]. | Clinical calcium 20050901 |
| Risedronate prevents bone loss in early postmenopausal women: a prospective randomized, placebo-controlled trial. | Climacteric : the journal of the International Menopause Society 20050901 |
| Prevention and treatment of corticosteroid-induced osteoporosis. | Yonsei medical journal 20050831 |
| Influence of bisphosphonates on the production of pro-inflammatory cytokines by activated human articular chondrocytes. | Cytokine 20050821 |
| Application of on-line Raman spectroscopy for characterizing relationships between drug hydration state and tablet physical stability. | International journal of pharmaceutics 20050811 |
| Bisphosphonates stimulate an endogenous nonselective cation channel in Xenopus oocytes: potential mechanism of action. | American journal of physiology. Cell physiology 20050801 |
| Autoactivation profiles of calcium-dependent matrix metalloproteinase-2 and -9 in inflammatory synovial fluid: effect of pyrophosphate and bisphosphonates. | Clinica chimica acta; international journal of clinical chemistry 20050801 |
| Alendronate (Fosamax) and risedronate (Actonel) revisited. | Obstetrics and gynecology 20050801 |
| Recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from the Group for the Respect of Ethics and Excellence in Science. | Seminars in arthritis and rheumatism 20050801 |
| The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial. | Archives of internal medicine 20050801 |
| Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke. | Archives of internal medicine 20050801 |
| Bone loss and the aromatase inhibitors. | British journal of cancer 20050801 |
| The effect of risedronate on bone mineralization as measured by micro-computed tomography with synchrotron radiation: correlation to histomorphometric indices of turnover. | Bone 20050701 |
| The use of bisphosphonates in the treatment of osteoporosis. | Current opinion in rheumatology 20050701 |
| Risedronate induced BOOP complicated with sarcoidosis. | Thorax 20050701 |
| Chronic diffuse sclerosing osteomyelitis treated with risedronate. | The Journal of rheumatology 20050701 |
| Bisphosphonate therapy improves the outcome of conventional periodontal treatment: results of a 12-month, randomized, placebo-controlled study. | Journal of periodontology 20050701 |
| Involvement of Ras/extracellular signal-regulated kinase, but not Akt pathway in risedronate-induced apoptosis of U937 cells and its suppression by cytochalasin B. | Biochemical pharmacology 20050615 |
| Risedronate in the treatment of Murine Chagas' disease. | Parasitology research 20050601 |
| Osteoporosis therapy: an example of putting evidence-based medicine into clinical practice. | QJM : monthly journal of the Association of Physicians 20050601 |
| A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis. | Health technology assessment (Winchester, England) 20050601 |
| Prediction of genotoxicity of chemical compounds by statistical learning methods. | Chemical research in toxicology 20050601 |
| Microcracks in cortical bone: how do they affect bone biology? | Current osteoporosis reports 20050601 |
| Exercise and pharmacological countermeasures for bone loss during long-duration space flight. | Gravitational and space biology bulletin : publication of the American Society for Gravitational and Space Biology 20050601 |
| [Quality of life in the treatment assessment of postmenopausal osteoporosis]. | Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20050601 |
| A bright future for osteoporosis treatment. | Drug news & perspectives 20050601 |
| [Marketing--alendronate versus risedronate]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20050519 |
| The prevention and treatment of osteoporosis: a review. | MedGenMed : Medscape general medicine 20050511 |
| Bisphosphonate inhibitors of Toxoplasma gondi growth: in vitro, QSAR, and in vivo investigations. | Journal of medicinal chemistry 20050505 |
| [To increase bone density faster and stronger]. | MMW Fortschritte der Medizin 20050505 |
| Current pharmacological treatment for fibrous dysplasia and perspectives for the future. | Joint, bone, spine : revue du rhumatisme 20050501 |
| Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women. | European journal of obstetrics, gynecology, and reproductive biology 20050501 |
| Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20050501 |
| Alendronate (Fosamax) and risedronate (Actonel) revisited. | The Medical letter on drugs and therapeutics 20050425 |
| Ibandronate (Boniva): a new oral bisphosphonate. | The Medical letter on drugs and therapeutics 20050425 |
| [Paget's disease and its therapeutic management]. | Presse medicale (Paris, France : 1983) 20050423 |
| Pyridinium-1-yl bisphosphonates are potent inhibitors of farnesyl diphosphate synthase and bone resorption. | Journal of medicinal chemistry 20050421 |
| [Calcium gaps in osteoporosis patients close. Blister pack simplifies comedication of calcium and bisphosphonates]. | MMW Fortschritte der Medizin 20050407 |
| [Excellent adjustment with greater action. To pay attention to improving compliance]. | MMW Fortschritte der Medizin 20050407 |
| Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20050401 |
| Structural and analytical characterization of three hydrates and an anhydrate form of risedronate. | Journal of pharmaceutical sciences 20050401 |
| [Bisphosphontes]. | Clinical calcium 20050401 |
| [Treatment with bisphosphonates: daily or once-weekly oral administration and intravenous injection]. | Clinical calcium 20050401 |
| Optimizing the management of postmenopausal osteoporosis with bisphosphonates: the emerging role of intermittent therapy. | Clinical therapeutics 20050401 |
| Vertebral fracture risk reduction with risedronate in post-menopausal women with osteoporosis: a meta-analysis of individual patient data. | Aging clinical and experimental research 20050401 |
| Treatment of postmenopausal osteoporosis. | Pharmacotherapy 20050401 |
| Bisphosphonates induce inflammation and rupture of atherosclerotic plaques in apolipoprotein-E null mice. | Biochemical and biophysical research communications 20050318 |
| Risedronate therapy for prevention of hip fracture after stroke in elderly women. | Neurology 20050308 |
| Oral antiresorptive therapy. | Current rheumatology reports 20050301 |
| Interleukin-6 and osteoprotegerin systems in Paget's disease of bone: relationship to risedronate treatment. | Bone 20050301 |
| Rapid prevention of vertebral fractures associated with osteoporosis. | Orthopedics 20050301 |
| Risedronate for prevention and treatment of osteoporosis in postmenopausal women. | Expert opinion on pharmacotherapy 20050301 |
| Glucocorticoid-induced osteoporosis: treatment options and guidelines. | Current osteoporosis reports 20050301 |
| [Pharmacological treatment of osteitis deformans (Paget's bone disease)]. | Ugeskrift for laeger 20050227 |
| [Evaluation of the effects of treatment of osteoporosis]. | Ugeskrift for laeger 20050227 |
| [Osteoporosis in the elderly--diagnosis and treatment]. | MMW Fortschritte der Medizin 20050217 |
| Alendronate and risedronate: reports of severe bone, joint, and muscle pain. | Archives of internal medicine 20050214 |
| How to prevent steroid induced osteoporosis. | Annals of the rheumatic diseases 20050201 |
| The efficacy and tolerability of risedronate on bone mineral density and bone turnover markers in osteoporotic Chinese women: a randomized placebo-controlled study. | Bone 20050201 |
| [FACT study: benefits of alendronate]. | MMW Fortschritte der Medizin 20050113 |
| Extemporaneous procedures for dissolving risedronate tablets for oral administration and for feeding tubes. | The Annals of pharmacotherapy 20050101 |
| Multiple vertebral fractures are associated with refractory reflux esophagitis in postmenopausal women. | Journal of bone and mineral metabolism 20050101 |
| Trochanteric hip fracture in an elderly patient with leprosy during osteoporosis treatment with risedronate and alfacalcidol. | Journal of bone and mineral metabolism 20050101 |
| Long-term disuse osteoporosis seems less sensitive to bisphosphonate treatment than other osteoporosis. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050101 |
| Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050101 |
| [Minodronic acid hydrate as a new therapeutic agent for osteoporosis]. | Clinical calcium 20050101 |
| Clinical pharmacology of potent new bisphosphonates for postmenopausal osteoporosis. | Treatments in endocrinology 20050101 |
| Interleukin-18 (IL-18) and matrix metalloproteinase-9 (MMP-9) in post-menopausal osteoporosis. | Archives of gerontology and geriatrics 20050101 |
| Structure-activity relationships of a new class of aromatic bisphosphonates that inhibit tumor cell proliferation in vitro. | Anticancer research 20050101 |
| Chondrosarcoma in Paget's disease of bone. | Clinical and experimental rheumatology 20050101 |
| Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]. | Arthritis research & therapy 20050101 |
| Pharmacological management of severe postmenopausal osteoporosis. | Drugs & aging 20050101 |
| Pharmacokinetics/pharmacodynamics of bisphosphonates: use for optimisation of intermittent therapy for osteoporosis. | Clinical pharmacokinetics 20050101 |
| The effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog rib. | Journal of bone and mineral metabolism 20050101 |
| Optimizing administration of bisphosphonates in women with postmenopausal osteoporosis. | Treatments in endocrinology 20050101 |
| Anti-resorptive therapy for the prevention of postmenopausal osteoporosis : when should treatment begin? | Treatments in endocrinology 20050101 |
| Hydrophilic and lipophilic radiopharmaceuticals as tracers in pharmaceutical development: in vitro--in vivo studies. | BMC nuclear medicine 20050101 |
| Systemic effects of fluticasone nasal spray: report of 2 cases. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20050101 |
| Effects of risedronate on femoral bone mineral density and bone strength in sciatic neurectomized young rats. | Journal of bone and mineral metabolism 20050101 |
| Segregation of a M404V mutation of the p62/sequestosome 1 (p62/SQSTM1) gene with polyostotic Paget's disease of bone in an Italian family. | Arthritis research & therapy 20050101 |
| Periodontal assessment of postmenopausal women receiving risedronate. | Menopause (New York, N.Y.) 20050101 |
| Uses and limitations of bone mineral density measurements in the management of osteoporosis. | MedGenMed : Medscape general medicine 20050101 |
| [Treatment of Paget's disease of bone with zoledronic acid]. | Revue medicale de Bruxelles 20050101 |
| Efficacy and safety of risedronate sodium in treatment of postmenopausal osteoporosis. | Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20050101 |
| [What do we need to know--what can we do?]. | Krankenpflege Journal 20050101 |
| Asthma and therapeutics: inhaled corticosteroids, corticosteroid osteoporosis, and the risk of fracture in chronic asthma. | Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20050101 |
| [Treatment of postmenopausal osteoporosis]. | La Revue du praticien 20041215 |
| Seven years of treatment with risedronate in women with postmenopausal osteoporosis. | Calcified tissue international 20041201 |
| Five years of treatment with risedronate and its effects on bone safety in women with postmenopausal osteoporosis. | Calcified tissue international 20041201 |
| Pharmaceutical care and community pharmacists' understanding of bisphosphonate dosing information. | Journal of clinical pharmacy and therapeutics 20041201 |
| Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis. | Current medical research and opinion 20041201 |
| Examination of antimicrobial activity of selected non-antibiotic drugs. | Acta poloniae pharmaceutica 20041201 |
| Oral antiresorptive therapy. | Current osteoporosis reports 20041201 |
| Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20041101 |
| Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old. | Journal of the American Geriatrics Society 20041101 |
| [Cost-effectiveness of osteoporosis treatment]. | Clinical calcium 20041101 |
| [Treatment of postmenopausal osteoporosis in 2004]. | Revue medicale de Liege 20041101 |
| Pharmacologic prevention of osteoporotic fractures. | American family physician 20041001 |
| Treating osteoporosis in post-menopausal women: a case approach. | Cleveland Clinic journal of medicine 20041001 |
| New treatments for brittle bones. | Annals of internal medicine 20040907 |
| Paget's disease of bone. | The Medical journal of Australia 20040906 |
| The purine transferase from Trypanosoma cruzi as a potential target for bisphosphonate-based chemotherapeutic compounds. | Bioorganic & medicinal chemistry letters 20040906 |
| Coming to grips with bone loss. | Science (New York, N.Y.) 20040903 |
| Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates. | Calcified tissue international 20040901 |
| Antiresorptive therapy conserves some periarticular bone and ligament mechanical properties after anterior cruciate ligament disruption in the rabbit knee. | Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20040901 |
| Nitrogen-containing bisphosphonate mechanism of action. | Mini reviews in medicinal chemistry 20040901 |
| Fracture protection in osteoporosis with risedronate. | Hospital medicine (London, England : 1998) 20040901 |
| [Weekly Fosamax tablet is significantly more effective than risedronate daily, as results of the Head-to-Head Study show]. | Praxis 20040901 |
| Management of osteoporosis: the Indian perspective. | Clinical calcium 20040901 |
| Preparation and evaluation of floating risedronate sodium Gelucire 39/01 matrices. | Acta pharmaceutica (Zagreb, Croatia) 20040901 |
| [Stability also depends on other parameters. Bone density--not a good indicator for fracture prevention]. | MMW Fortschritte der Medizin 20040805 |
| [Are there differences in bisphosphonates? (interview by Dr. Beate Schumacher)]. | MMW Fortschritte der Medizin 20040805 |
| Osteoblast proliferation and maturation by bisphosphonates. | Biomaterials 20040801 |
| Management of Paget's disease of bone. | Rheumatology (Oxford, England) 20040801 |
| The effect of prophylactic treatment with risedronate on stress fracture incidence among infantry recruits. | Bone 20040801 |
| Effects of risedronate on bone density in anorexia nervosa. | The Journal of clinical endocrinology and metabolism 20040801 |
| Japanese orthopedists' interests in prevention of fractures in the elderly from falls. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20040701 |
| Prevention and management of osteoporosis in women with breast cancer and men with prostate cancer. | Current oncology reports 20040701 |
| The role of bisphosphonates in breast and prostate cancers. | Endocrine-related cancer 20040601 |
| Hip fracture prevention in postmenopausal women. | Obstetrical & gynecological survey 20040601 |
| Prevention of glucocorticoid-induced osteoporosis. | Southern medical journal 20040601 |
| [Faster and long-lasting protection with risedronate. With strengthened bones longer self-sufficient]. | MMW Fortschritte der Medizin 20040527 |
| [Risedronate affects bone strength, too. Faster protective effect on microarchitecture]. | MMW Fortschritte der Medizin 20040527 |
| [Risk of osteoporosis in postmenopausal women. When is bone density measurement indicated?]. | MMW Fortschritte der Medizin 20040520 |
| Mucosal irritative and healing impairment action of risedronate in rat stomachs: comparison with alendronate. | Journal of gastroenterology and hepatology 20040501 |
| Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties. | Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20040501 |
| Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosis. | Current medical research and opinion 20040501 |
| Contribution of Complementarity-Determining Region 3 of the T-Cell Receptor Vδ2 Chain to the Recognition of Aminobisphosphonates by Human γδ T-Cells. | International journal of hematology 20040501 |
| [Bone quality in treatment with raroxifene ]. | Clinical calcium 20040501 |
| Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography. | Bone 20040401 |
| Efficacy of risedronate on clinical vertebral fractures within six months. | Current medical research and opinion 20040401 |
| Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis. | Current medical research and opinion 20040401 |
| 7: Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual's absolute risk of fracture. | The Medical journal of Australia 20040315 |
| Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi. | International journal of antimicrobial agents 20040301 |
| Antiparasitic activity of risedronate in a murine model of acute Chagas' disease. | International journal of antimicrobial agents 20040301 |
| Statistical validation of surrogate endpoints: is bone density a valid surrogate for fracture? | Journal of musculoskeletal & neuronal interactions 20040301 |
| Rational use of oral bisphosphonates for the treatment of osteoporosis. | Current osteoporosis reports 20040301 |
| Selective in vitro antioxidant properties of bisphosphonates. | Biochemical and biophysical research communications 20040213 |
| [Data comparison of osteoporosis patients demonstrates nasal administration is not optimal]. | MMW Fortschritte der Medizin 20040212 |
| Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis. | Calcified tissue international 20040201 |
| An update on bisphosphonates. | Current rheumatology reports 20040201 |
| Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20040201 |
| Relationship between changes in bone mineral density and fracture risk reduction with antiresorptive drugs: some issues with meta-analyses. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20040201 |
| [New guideline for the treatment of osteoporosis]. | Nihon rinsho. Japanese journal of clinical medicine 20040201 |
| [Risedronate treatment for osteoporosis]. | Nihon rinsho. Japanese journal of clinical medicine 20040201 |
| [VERT(Vertebral Efficacy with Risedronate Therapy)-MN(Multinational) Study and VERT-NA(North America) Study]. | Nihon rinsho. Japanese journal of clinical medicine 20040201 |
| [Combination therapy of bisphosphonate and estrogen for osteoporosis]. | Nihon rinsho. Japanese journal of clinical medicine 20040201 |
| Quantitative structure-activity relationships for gammadelta T cell activation by bisphosphonates. | Journal of medicinal chemistry 20040115 |
| Effects of bisphosphonates on the growth of Entamoeba histolytica and Plasmodium species in vitro and in vivo. | Journal of medicinal chemistry 20040101 |
| The effects of binge alcohol exposure on bone resorption and biomechanical and structural properties are offset by concurrent bisphosphonate treatment. | Alcoholism, clinical and experimental research 20040101 |
| Secondary osteoporosis: underlying disease and the risk for glucocorticoid-induced osteoporosis. | Clinical therapeutics 20040101 |
| Clinical trial of risedronate in Japanese volunteers: single and multiple oral dose studies. | Journal of bone and mineral metabolism 20040101 |
| Clinical trial of risedronate in Japanese volunteers: a study on the effects of timing of dosing on absorption. | Journal of bone and mineral metabolism 20040101 |
| Comparison of risedronate to alendronate and calcitonin for early reduction of nonvertebral fracture risk: results from a managed care administrative claims database. | Journal of managed care pharmacy : JMCP 20040101 |
| The osteoporosis care gap in Canada. | BMC musculoskeletal disorders 20040101 |
| Parathyroid hormone. | The Journal of the American Academy of Orthopaedic Surgeons 20040101 |
| [Osteitis deformans--Paget's disease]. | Wiener medizinische Wochenschrift (1946) 20040101 |
| Antiresorption therapy and reduction in fracture susceptibility in the osteoporotic elderly patient: open study. | European review for medical and pharmacological sciences 20040101 |
| Markers of bone resorption in bisphosphonate therapy of Paget's disease. | Clinical and experimental rheumatology 20040101 |
| [Consistent therapeutic success in osteoporosis]. | Krankenpflege Journal 20040101 |
| Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2. | Journal of bone and mineral metabolism 20040101 |
| A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate: a randomized, double-masked trial. | Journal of bone and mineral metabolism 20040101 |
| Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk. | Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20040101 |
| Toward new horizons: the future of bisphosphonate therapy. | The oncologist 20040101 |
| Combining bisphosphonates with hormone therapy for postmenopausal osteoporosis. | Treatments in endocrinology 20040101 |
| Alendronate and risedronate for the treatment of postmenopausal osteoporosis: clinical profiles of the once-weekly and once-daily dosing formulations. | MedGenMed : Medscape general medicine 20040101 |
| Health-economic comparison of three recommended drugs for the treatment of osteoporosis. | International journal of clinical pharmacology research 20040101 |
| [Bisphosphonates]. | Clinical calcium 20040101 |
| [Update 2004. Osteoporosis--management--current status]. | Krankenpflege Journal 20040101 |
| [Routine osteoporosis therapy]. | Krankenpflege Journal 20040101 |
| Skeletal benefit after one year of risedronate therapy in patients with rheumatoid arthritis and glucocorticoid-induced osteoporosis: a prospective study. | International journal of clinical pharmacology research 20040101 |
| [Current trends and future perspectives in the therapy of the osteoporosis]. | La Clinica terapeutica 20040101 |
| Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption. | Endocrinology 20031201 |
| Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20031201 |
| Spectrophotometric determination of some drugs for osteoporosis. | Chemical & pharmaceutical bulletin 20031201 |
| A prospective study of risedronate on regional bone metabolism and blood flow at the lumbar spine measured by 18F-fluoride positron emission tomography. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20031201 |
| Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs. | Bone 20031201 |
| [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium]. | Zeitschrift fur Rheumatologie 20031201 |
| Patent news. | IDrugs : the investigational drugs journal 20031201 |
| An approach to postmenopausal osteoporosis treatment: a case study review. | Journal of the American Academy of Nurse Practitioners 20031201 |
| Osteoporosis management in the new millennium. | Primary care 20031201 |
| Use of highly potent bisphosphonates in the treatment of osteoporosis. | Current osteoporosis reports 20031201 |
| 3-D QSAR investigations of the inhibition of Leishmania major farnesyl pyrophosphate synthase by bisphosphonates. | Journal of medicinal chemistry 20031120 |
| Properties of bisphosphonates in the 13762 rat mammary carcinoma model of tumor-induced bone resorption. | Clinical cancer research : an official journal of the American Association for Cancer Research 20031115 |
| Risedronate preserves bone architecture in early postmenopausal women in 1 year as measured by three-dimensional microcomputed tomography. | Calcified tissue international 20031101 |
| Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. | Arthritis and rheumatism 20031101 |
| Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates. | Bone 20031101 |
| Combined treatment with vitamin k2 and bisphosphonate in postmenopausal women with osteoporosis. | Yonsei medical journal 20031030 |
| Aging bone and osteoporosis: strategies for preventing fractures in the elderly. | Archives of internal medicine 20031013 |
| Medical treatment of vertebral osteoporosis. | European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 20031001 |
| Alternate options to hormone replacement therapy for osteoporosis. | The Journal of the American Osteopathic Association 20031001 |
| Management of osteoporosis due to ovarian failure. | Medical and pediatric oncology 20030901 |
| Review of guidelines for testing and treatment of osteoporosis. | Current osteoporosis reports 20030901 |
| Determination of risedronate in human urine by column-switching ion-pair high-performance liquid chromatography with ultraviolet detection. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030825 |
| Effect of hospitalist consultation on treatment of osteoporosis in hip fracture patients. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20030801 |
| Present and future pharmacotherapy for osteoporosis. | Drugs of today (Barcelona, Spain : 1998) 20030801 |
| [Evidence-based therapy of osteoporosis--comment on DMW 17/2003]. | Deutsche medizinische Wochenschrift (1946) 20030725 |
| Bisphosphonates: new indications and methods of administration. | Current opinion in rheumatology 20030701 |
| Show us the numbers. | Canadian family physician Medecin de famille canadien 20030701 |
| Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro. | British journal of cancer 20030616 |
| [Therapy of osteoporosis with bisphosphonate. Bone quality maintained over years]. | MMW Fortschritte der Medizin 20030605 |
| Use of matched historical controls to evaluate the anti-fracture efficacy of once-a-week risedronate. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20030601 |
| Identifying the osteopenic patient and preventing worsening of the disease. | Current women's health reports 20030601 |
| Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20030601 |
| Risk of fracture and treatment to prevent osteoporosis-related fracture in postmenopausal women. A review. | The Journal of reproductive medicine 20030601 |
| Canine cancellous bone microarchitecture after one year of high-dose bisphosphonates. | Calcified tissue international 20030601 |
| [To treat effectively without delay. The data on fractures decisive]. | MMW Fortschritte der Medizin 20030522 |
| Farnesyl pyrophosphate synthase is an essential enzyme in Trypanosoma brucei. In vitro RNA interference and in vivo inhibition studies. | The Journal of biological chemistry 20030509 |
| [For patients with osteoporosis-induced fracture the emergency brake must be pulled. Every 4th patient as a recurrence in the following year]. | MMW Fortschritte der Medizin 20030508 |
| Comparing therapies for postmenopausal osteoporosis prevention and treatment. | The Annals of pharmacotherapy 20030501 |
| Tolerability and compliance with risedronate in clinical practice. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20030501 |
| A double-blind dose-ranging study of risedronate in Japanese patients with osteoporosis (a study by the Risedronate Late Phase II Research Group). | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20030501 |
| Analysis of 1-year vertebral fracture risk reduction data in treatments for osteoporosis. | Southern medical journal 20030501 |
| Bisphosphonate treatment of osteoporosis. | Clinics in geriatric medicine 20030501 |
| [Osteoporosis in men]. | Deutsche medizinische Wochenschrift (1946) 20030425 |
| Involvement of vacuolar H+ -ATPase in incorporation of risedronate into osteoclasts. | Bone 20030401 |
| Advances in osteoporosis therapy. 2003 update of practical guidelines. | Canadian family physician Medecin de famille canadien 20030401 |
| Canadian consensus on osteoporosis. Preventing osteoporosis among postmenopausal women. | Canadian family physician Medecin de famille canadien 20030401 |
| Preventing osteoporotic fractures with bisphosphonates: a review of the efficacy and tolerability. | Aging clinical and experimental research 20030401 |
| [Osteoporosis therapy. Bisphosphonates compared]. | MMW Fortschritte der Medizin 20030327 |
| Calcitonin. | Endocrinology and metabolism clinics of North America 20030301 |
| [Vertebral body fracture as incidental finding in thoracic radiography. Family physician usually does not learn about it]. | MMW Fortschritte der Medizin 20030220 |
| Effects of risedronate, alendronate, and etidronate on the viability and activity of rat bone marrow stromal cells in vitro. | Calcified tissue international 20030201 |
| Mechanisms of osteolytic bone metastases in breast carcinoma. | Cancer 20030201 |
| Editorial: greater risk, greater benefit--true or false? | The Journal of clinical endocrinology and metabolism 20030201 |
| Risedronate prevents new vertebral fractures in postmenopausal women at high risk. | The Journal of clinical endocrinology and metabolism 20030201 |
| Three hydrates of the bisphosphonate risedronate, consisting of one molecular and two ionic structures. | Acta crystallographica. Section C, Crystal structure communications 20030201 |
| Bisphosphonate mechanism of action. | Current rheumatology reports 20030201 |
| Glucocorticoid-induced osteoporosis: pathogenesis, diagnosis, and management. | Preventive medicine 20030201 |
| Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience. | Bone 20030201 |
| [Possible mechanism of the specific action of bisphosphonates on osteoclasts]. | Nihon rinsho. Japanese journal of clinical medicine 20030201 |
| [Effects of bisphosphonate on trabecular microstructure]. | Nihon rinsho. Japanese journal of clinical medicine 20030201 |
| [Development of bisphosphonates]. | Nihon rinsho. Japanese journal of clinical medicine 20030201 |
| [Risedronate]. | Nihon rinsho. Japanese journal of clinical medicine 20030201 |
| [Methodology of bone mass measurement]. | Nihon rinsho. Japanese journal of clinical medicine 20030201 |
| [Treatment of osteoporosis provided from the orthopaedic surgeon's standpoint]. | Nihon rinsho. Japanese journal of clinical medicine 20030201 |
| [Glucocorticoid-induced osteoporosis]. | Nihon rinsho. Japanese journal of clinical medicine 20030201 |
| Role of gastric mucosal and gastric juice cytokine concentrations in development of bisphosphonate damage to gastric mucosa. | Digestive diseases and sciences 20030201 |
| [Evidences and the taking measurements against G-I tract adverse events in amino bisphosphonate]. | Clinical calcium 20030201 |
| [Prevention of hip fracture in the elderly]. | Clinical calcium 20030201 |
| [Economic assessment based on a clinical study of risedronate. Fracture prevention in elderly women with osteoporosis is cost-effective]. | Lakartidningen 20030109 |
| A comprehensive review of treatments for postmenopausal osteoporosis. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20030101 |
| Bone density changes with once weekly risedronate in postmenopausal women. | Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20030101 |
| Drugs in development: bisphosphonates and metalloproteinase inhibitors. | Arthritis research & therapy 20030101 |
| The Canadian celiac health survey--the Ottawa chapter pilot. | BMC gastroenterology 20030101 |
| Therapeutic options: an evidence-based approach to prevention and treatment of osteoporosis. | International journal of fertility and women's medicine 20030101 |
| [Male osteoporosis: current treatments and future options]. | La Clinica terapeutica 20030101 |
| Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled study. | Current medical research and opinion 20030101 |
| New insights into the molecular mechanisms of action of bisphosphonates. | Current pharmaceutical design 20030101 |
| Risedronate for the prevention and treatment of postmenopausal osteoporosis. | The Cochrane database of systematic reviews 20030101 |
| Glucocorticoid-induced osteoporosis. | Hormone research 20030101 |
| [Large clinical trials for osteoporosis]. | Therapie 20030101 |
| New approaches to pharmacological treatment of osteoporosis. | Bulletin of the World Health Organization 20030101 |
| [Bisphosphonates in the prevention of vertebral and non-vertebral fractures in postmenopausal women with osteoporosis]. | Reumatizam 20030101 |
| Pharmacoeconomic analysis of osteoporosis treatment with risedronate. | International journal of clinical pharmacology research 20030101 |
| Risedronate once a week. | Treatments in endocrinology 20030101 |
| A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20021201 |
| Perspectives on the Women's Health Initiative trial of hormone replacement therapy. | Obstetrics and gynecology 20021201 |
| Medications for postmenopausal osteoporosis prevention. | Harvard women's health watch 20021201 |
| Risedronate prevents hip fractures, but who should get therapy? | Cleveland Clinic journal of medicine 20021201 |
| [Osteoporosis]. | Der Internist 20021201 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20021201 |
| [Treatments of Osteoporosis with SERM and their EBM]. | Clinical calcium 20021201 |
| [Osteoporosis in the aged male]. | Presse medicale (Paris, France : 1983) 20021123 |
| Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. | Cancer research 20021115 |
| Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis. | Bone 20021101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20021101 |
| [Weeks of pain, vertebral body fractures during sleep, invalidism. Save your osteoporosis patients from this fate]. | MMW Fortschritte der Medizin 20021031 |
| Once-a-week risedronate (actonel). | The Medical letter on drugs and therapeutics 20021014 |
| Effect of bisphosphonates on viability, proliferation, and dexamethasone-induced apoptosis of articular chondrocytes. | Annals of the rheumatic diseases 20021001 |
| Bisphosphonates and the upper gastrointestinal tract: skeletal gain without visceral pain? | Mayo Clinic proceedings 20021001 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20021001 |
| [Treatment of osteoporosis. Not only measurements count]. | MMW Fortschritte der Medizin 20020905 |
| 14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status. | The Journal of rheumatology 20020901 |
| Gateways to Clinical Trials. | Methods and findings in experimental and clinical pharmacology 20020901 |
| [Hormone replacement therapy for postmenopausal osteoporosis]. | Clinical calcium 20020901 |
| Bisphosphonates. | Maturitas 20020830 |
| Commentary on: Bone mineral density and fracture prevalence in long-term kidney graft recipients. | Transplantation 20020827 |
| The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis. | Calcified tissue international 20020801 |
| Prevention of bone loss in ovariectomized rats by combined treatment with risedronate and 1alpha,25-dihydroxyvitamin D3. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20020801 |
| What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates. | Digestive diseases and sciences 20020801 |
| Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. | Endocrine reviews 20020801 |
| Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. | Endocrine reviews 20020801 |
| Osteoporosis in elderly: prevention and treatment. | Clinics in geriatric medicine 20020801 |
| [Risedronate]. | Clinical calcium 20020801 |
| [Osteoporosis therapy. A comparison of bisphosphonates]. | MMW Fortschritte der Medizin 20020711 |
| An investigation of bone resorption and Dictyostelium discoideum growth inhibition by bisphosphonate drugs. | Journal of medicinal chemistry 20020704 |
| Activity of bisphosphonates against Trypanosoma brucei rhodesiense. | Journal of medicinal chemistry 20020704 |
| Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats. | Endocrinology 20020701 |
| Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by three-dimensional microcomputed tomography. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20020701 |
| Bone quality: getting closer to a definition. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20020701 |
| Treatment of postmenopausal osteoporosis. | Lancet (London, England) 20020608 |
| Assessment of mortality in patients enrolled in a risedronate clinical trial program: a retrospective cohort study. | Regulatory toxicology and pharmacology : RTP 20020601 |
| Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20020528 |
| Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates and diphosphates: a potential route to new bone antiresorption and antiparasitic agents. | Journal of medicinal chemistry 20020523 |
| The bisphosphonate zoledronic acid impairs Ras membrane [correction of impairs membrane] localisation and induces cytochrome c release in breast cancer cells. | British journal of cancer 20020506 |
| The cost utility of bisphosphonate treatment in established osteoporosis. | QJM : monthly journal of the Association of Physicians 20020501 |
| Risedronate: a new oral bisphosphonate. | Clinical therapeutics 20020501 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20020501 |
| [Bisphosphonates and adhesion molecules]. | Clinical calcium 20020501 |
| [Episcleritis secondary to risedronate]. | Medicina clinica 20020427 |
| [When osteoporosis first manifests itself. Without therapy the next fracture threatens]. | MMW Fortschritte der Medizin 20020404 |
| Risedronate for the prevention of fractures in postmenopausal osteoporosis. | The Annals of pharmacotherapy 20020401 |
| [Osteoporosis - Evidence based therapy]. | Zeitschrift fur Gastroenterologie 20020401 |
| [Risedronate, a new diphosphonate in osteoporosis and Paget's disease]. | Presse medicale (Paris, France : 1983) 20020302 |
| Upper gastrointestinal tract safety of risedronate: a pooled analysis of 9 clinical trials. | Mayo Clinic proceedings 20020301 |
| Risedronate for the prevention and treatment of corticosteroid-induced osteoporosis. | The Annals of pharmacotherapy 20020301 |
| [Risedronate: clinical usage]. | Nihon rinsho. Japanese journal of clinical medicine 20020301 |
| Antiresorptive treatment of postmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint. | Endocrine reviews 20020201 |
| Therapies to improve bone mineral density and reduce the risk of fracture: clinical trial results. | The Journal of reproductive medicine 20020101 |
| Effect of vitamin D on bone mineral density of elderly patients with osteoporosis responding poorly to bisphosphonates. | BMC musculoskeletal disorders 20020101 |
| Direct effects of bisphosphonates on breast cancer cells. | Breast cancer research : BCR 20020101 |
| Development of bisphosphonates. | Breast cancer research : BCR 20020101 |
| Actions of bisphosphonates in animal models of breast cancer. | Breast cancer research : BCR 20020101 |
| Medical treatment of osteoporosis--increasing options. | Annals of the Academy of Medicine, Singapore 20020101 |
| The underuse of therapy in the secondary prevention of hip fractures. | Drugs & aging 20020101 |
| The potential of parathyroid hormone as a therapy for osteoporosis. | International journal of fertility and women's medicine 20020101 |
| Risedronate reduces the risk of first vertebral fracture in osteoporotic women. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20020101 |
| Response of bone mineral density to once-weekly administration of risedronate. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20020101 |
| Alendronate and risedronate: what you need to know about their upper gastrointestinal tract toxicity. | Reviews in gastroenterological disorders 20020101 |
| Long-term tolerability of the bisphosphonates in postmenopausal osteoporosis: a comparative review. | Drug safety 20020101 |
| A review of combination regimens for osteoporosis--prevention and treatment. | International journal of fertility and women's medicine 20020101 |
| [Osteoporosis: diagnosis, prevention and treatment]. | Medicina (Kaunas, Lithuania) 20020101 |
| [Osteoporosis: diagnosis and treatment of vertebral fractures]. | Medicina (Kaunas, Lithuania) 20020101 |
| [Guidelines for drug therapy of postmenopausal osteoporosis]. | Wiener medizinische Wochenschrift (1946) 20020101 |
| Management of primary osteoporosis. | Acta clinica Belgica 20020101 |
| Prevention and treatment of osteoporosis. | Clinical cornerstone 20020101 |
| Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages. | The Journal of biological chemistry 20011221 |
| [Therapy of osteoporosis. Risk factors alone are not an indication]. | MMW Fortschritte der Medizin 20011206 |
| Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis. | Bone 20011201 |
| Anabolic agents for treating postmenopausal osteoporosis. | Joint, bone, spine : revue du rhumatisme 20011201 |
| Review of risedronate in the treatment of osteoporosis. | Expert opinion on pharmacotherapy 20011201 |
| Bisphosphonates for the treatment of postmenopausal osteoporosis: clinical studies of etidronate and alendronate. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20011201 |
| Risedronate for the prevention and treatment of postmenopausal osteoporosis: results from recent clinical trials. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20011201 |
| [Economic aspects of osteoporosis therapy. What does a prevented fracture cost?]. | MMW Fortschritte der Medizin 20011122 |
| A method to assess the proportion of treatment effect explained by a surrogate endpoint. | Statistics in medicine 20011115 |
| Role of alendronate and risedronate in preventing and treating osteoporosis. | Cleveland Clinic journal of medicine 20011101 |
| The role of serial bone mineral density testing for osteoporosis. | Journal of women's health & gender-based medicine 20011101 |
| Bisphosphonate treatment suppresses not only stochastic remodeling but also the targeted repair of microdamage. | Calcified tissue international 20011101 |
| [Alternatives to hormonal treatment for the prevention of postmenopausal osteoporosis: the bisphosphonates]. | Gynecologie, obstetrique & fertilite 20011101 |
| [Osteoporosis. Fracture as alarm signal]. | MMW Fortschritte der Medizin 20011011 |
| Nitrogen-containing bisphosphonates induce apoptosis of Caco-2 cells in vitro by inhibiting the mevalonate pathway: a model of bisphosphonate-induced gastrointestinal toxicity. | Bone 20011001 |
| Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH. | Bone 20011001 |
| Paget's disease of the spine and its management. | European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 20011001 |
| Alendronate for the treatment of osteoporosis in men. | Calcified tissue international 20011001 |
| Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy. | Calcified tissue international 20011001 |
| Tolerability of risedronate in postmenopausal women intolerant of alendronate. | Aging (Milan, Italy) 20011001 |
| Evaluation and treatment of postmenopausal osteoporosis. | The American journal of managed care 20010925 |
| Bisphosphonates are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase. | The Journal of biological chemistry 20010907 |
| [Optimizing treatment of osteoporosis. Rapidly effective therapy lowers fracture risk in 1 year up to 70%]. | MMW Fortschritte der Medizin 20010906 |
| [Risedronate now also approved for hip fractures. Study discloses significant risk reduction in proximal femoral neck fractures]. | MMW Fortschritte der Medizin 20010906 |
| Vgamma2Vdelta2 T-cell receptor-mediated recognition of aminobisphosphonates. | Blood 20010901 |
| Pharmacologic therapy for the treatment and prevention of osteoporosis. | The Nursing clinics of North America 20010901 |
| Bisphosphonates for osteoporosis. | Drug and therapeutics bulletin 20010901 |
| Risedronate: a new oral bisphosphonate. | Clinical therapeutics 20010901 |
| Osteoporosis in children and adolescent girls: case report of idiopathic juvenile osteoporosis and review of the literature. | Obstetrical & gynecological survey 20010801 |
| The in-vitro porcine adhesion model is not predictive of the esophageal transit of risedronate tablets in humans. | International journal of pharmaceutics 20010717 |
| The use of scintigraphy to demonstrate the rapid esophageal transit of the oval film-coated placebo risedronate tablet compared to a round uncoated placebo tablet when administered with minimal volumes of water. | International journal of pharmaceutics 20010717 |
| [Bisphosphonate treatment prevents hip fractures in 70-79 year old women with osteoporotic vertebral fractures]. | Nederlands tijdschrift voor geneeskunde 20010714 |
| Role of bisphosphonates and calcitonin in the prevention and treatment of osteoporosis. | Best practice & research. Clinical rheumatology 20010701 |
| [Fluorides and bisphosphonates in the treatment of osteoporosis]. | Der Orthopade 20010701 |
| (31)P NMR of apicomplexans and the effects of risedronate on Cryptosporidium parvum growth. | Biochemical and biophysical research communications 20010615 |
| Osteoporosis in men. | American family physician 20010615 |
| Re: Lanza et al.--Endoscopic comparison of alendronate and risedronate. | The American journal of gastroenterology 20010601 |
| Ocular adverse effects of alendronic acid. | Prescrire international 20010601 |
| The effect of risedronate on the risk of hip fracture in elderly women. | The New England journal of medicine 20010531 |
| The effect of risedronate on the risk of hip fracture in elderly women. | The New England journal of medicine 20010531 |
| The effect of risedronate on the risk of hip fracture in elderly women. | The New England journal of medicine 20010531 |
| Absolute vs. relative numbers in evaluating drug therapy. | American family physician 20010515 |
| [Therapy of osteoporosis from the viewpoint of evidence-based medicine]. | Medizinische Klinik (Munich, Germany : 1983) 20010515 |
| [Bisphosphonates in osteoporosis. Significantly reduces risk of fracture]. | MMW Fortschritte der Medizin 20010503 |
| Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. | Bone 20010501 |
| The role of combination treatment for osteoporosis. | The Journal of clinical endocrinology and metabolism 20010501 |
| Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women. | The Journal of clinical endocrinology and metabolism 20010501 |
| Risedronate: clinical usage. | International journal of clinical practice 20010501 |
| Maintenance of vertebral body bone mass and strength created by human parathyroid hormone treatment in ovariectomized rats. | Bone 20010401 |
| Consensus statement on the modern therapy of Paget's disease of bone from a Western Osteoporosis Alliance symposium. Biannual Foothills Meeting on Osteoporosis, Calgary, Alberta, Canada, September 9-10, 2000. | Clinical therapeutics 20010401 |
| Once-a-week alendronate (Fosamax). | The Medical letter on drugs and therapeutics 20010319 |
| Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy. | Journal of medicinal chemistry 20010315 |
| Maintenance of cortical bone in human parathyroid hormone(1-84)-treated ovariectomized rats. | Bone 20010301 |
| Hip fractures: do preventive drugs work for all? | Health news (Waltham, Mass.) 20010301 |
| Evidence-based medicine: putting theory into practice. | Hospital medicine (London, England : 1998) 20010301 |
| Risedronate: a clinical review. | Archives of internal medicine 20010212 |
| Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. | The Journal of pharmacology and experimental therapeutics 20010201 |
| Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation. | Molecular pharmacology 20010201 |
| Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. | The New England journal of medicine 20010201 |
| Treatment of osteoporosis with bisphosphonates. | Rheumatic diseases clinics of North America 20010201 |
| Risedronate pharmacokinetics and intra- and inter-subject variability upon single-dose intravenous and oral administration. | Pharmaceutical research 20010201 |
| Oesophageal transit, disintegration and gastric emptying of a film-coated risedronate placebo tablet in gastro-oesophageal reflux disease and normal control subjects. | Alimentary pharmacology & therapeutics 20010101 |
| Effect of high doses of oral risedronate (20 mg/day) on serum parathyroid hormone levels and urinary collagen cross-link excretion in postmenopausal women with spinal osteoporosis. | Bone 20010101 |
| Risedronate increases bone mineral density and reduces the vertebral fracture incidence in postmenopausal women. | Clinical and experimental rheumatology 20010101 |
| Prevention and treatment of osteoporosis. | Clinical medicine (London, England) 20010101 |
| Risedronate: a review of its pharmacological properties and clinical use in resorptive bone disease. | Drugs 20010101 |
| New possibilities for diagnosis and treatment of osteoporosis. | International journal of fertility and women's medicine 20010101 |
| Hormone replacement therapy and prevention of vertebral fractures: a meta-analysis of randomised trials. | BMC musculoskeletal disorders 20010101 |
| Risedronate treatment and extended fracture protection in postmenopausal women. | Clinical and experimental rheumatology 20010101 |
| Osteoporosis in men. | Orthopedic nursing 20010101 |
| Comparison insight dual X-ray absorptiometry (DXA), histomorphometry, ash weight, and morphometric indices for bone evaluation in an animal model (the orchidectomized rat) of male osteoporosis. | Calcified tissue international 20010101 |
| [Patients with fractures are in the front line for osteoporosis treatment but how to treat?]. | Duodecim; laaketieteellinen aikakauskirja 20010101 |
| [Efficacy and safety assessments of pharmaceutical agents]. | Clinical calcium 20010101 |
| Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase. | Archives of biochemistry and biophysics 20000101 |
| Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 19980401 |
| Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate. | The Journal of clinical endocrinology and metabolism |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.